Salim S. Virani

Q: What Schools Are Affiliated With Salim S. Virani

Salim S. Virani is affiliated with the following schools: Yale University, Emory University, University of Minnesota, Florida International University, Stanford University, Baylor College of Medicine, Johns Hopkins University

Salim S. Virani's AcademicInfluence.com Rankings

Salim S. Virani

Computer Science

#4216

World Rank

#4437

Historical Rank

Machine Learning

#759

World Rank

#770

Historical Rank

Artificial Intelligence

#967

World Rank

#985

Historical Rank

Database

#1442

World Rank

#1517

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Salim S. Virani's Degrees

PhD Computer Science Stanford University
Masters Computer Science Stanford University
Bachelors Computer Science Stanford University

Similar Degrees You Can Earn

Why Is Salim S. Virani Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Salim S. Virani's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association (2017) (6958)
Heart Disease and Stroke Statistics—2015 Update: A Report From the American Heart Association (2015) (6172)
Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association (2016) (6143)
Heart disease and stroke statistics--2013 update: a report from the American Heart Association. (2013) (5499)
Heart disease and stroke statistics--2012 update: a report from the American Heart Association. (2012) (5371)
Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association (2019) (4996)
Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association (2018) (4722)
Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association (2020) (3926)
Heart disease and stroke statistics--2014 update: a report from the American Heart Association. (2014) (3420)
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (2019) (2909)
Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. (2014) (2617)
Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association. (2013) (1897)
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (2019) (1880)
Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association. (2021) (1870)
Executive Summary: Heart Disease and Stroke Statistics—2015 Update A Report From the American Heart Association (2011) (1581)
Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association. (2012) (1496)
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (2019) (986)
Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association (2022) (935)
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (2019) (817)
Cardiac Troponin T Measured by a Highly Sensitive Assay Predicts Coronary Heart Disease, Heart Failure, and Mortality in the Atherosclerosis Risk in Communities Study (2011) (700)
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary. (2019) (599)
Heart Disease and Stroke Statistics – At-a-Glance (2015) (551)
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease. (2019) (526)
Small Dense Low-Density Lipoprotein-Cholesterol Concentrations Predict Risk for Coronary Heart Disease: The Atherosclerosis Risk in Communities (ARIC) Study (2014) (355)
National Trends in Statin Use and Expenditures in the US Adult Population From 2002 to 2013: Insights From the Medical Expenditure Panel Survey (2017) (268)
Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease: A Special Report From the American Heart Association and American College of Cardiology. (2019) (222)
Perioperative Beta Blockade in Noncardiac Surgery: A Systematic Review for the 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery A Report of the American College of Cardiology/American Heart Association Task Force on Practice G (2014) (200)
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (2019) (192)
Associations Between Lipoprotein(a) Levels and Cardiovascular Outcomes in Black and White Subjects: The Atherosclerosis Risk in Communities (ARIC) Study (2011) (185)
The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk. (2018) (183)
A Systematic Review of the Prevalence and Outcomes of Ideal Cardiovascular Health in US and Non-US Populations. (2016) (177)
Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association (2016) (175)
Dyslipidemia, Coronary Artery Calcium, and Incident Atherosclerotic Cardiovascular Disease: Implications for Statin Therapy From the Multi-Ethnic Study of Atherosclerosis (2014) (168)
Postprandial Hypertriglyceridemia Increases Circulating Levels of Endothelial Cell Microparticles (2004) (165)
Association of Statin Adherence With Mortality in Patients With Atherosclerotic Cardiovascular Disease (2019) (163)
Perioperative beta blockade in noncardiac surgery: a systematic review for the 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice (2014) (139)
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (2019) (132)
Association Between Intensity of Statin Therapy and Mortality in Patients With Atherosclerotic Cardiovascular Disease (2017) (127)
Gender disparities in evidence-based statin therapy in patients with cardiovascular disease. (2015) (127)
Carotid Arterial Wall Characteristics Are Associated With Incident Ischemic Stroke But Not Coronary Heart Disease in the Atherosclerosis Risk in Communities (ARIC) Study (2012) (118)
Implications of the 2013 ACC/AHA cholesterol guidelines for adults in contemporary cardiovascular practice: insights from the NCDR PINNACLE registry. (2014) (107)
Patient‐Reported Reasons for Declining or Discontinuing Statin Therapy: Insights From the PALM Registry (2019) (107)
Remnant-Like Particle Cholesterol, Low-Density Lipoprotein Triglycerides, and Incident Cardiovascular Disease. (2018) (103)
Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease: A Special Report From the American Heart Association and American College of Cardiology. (2019) (102)
Sex Differences in the Use of Statins in Community Practice. (2019) (97)
Relationship of the triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio to the remainder of the lipid profile: The Very Large Database of Lipids-4 (VLDL-4) study. (2015) (91)
Effect of heart failure on the outcome of COVID-19 — A meta analysis and systematic review (2020) (89)
Adoption of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline in Cardiology Practices Nationwide (2017) (87)
2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypertriglyceridemia: A Report of the American College of Cardiology Solution Set Oversight Committee. (2021) (84)
Updated Cost-effectiveness Assessments of PCSK9 Inhibitors From the Perspectives of the Health System and Private Payers: Insights Derived From the FOURIER Trial (2017) (84)
Troponin T and N-terminal pro-B-type natriuretic peptide: a biomarker approach to predict heart failure risk--the atherosclerosis risk in communities study. (2013) (84)
Non-HDL cholesterol as a metric of good quality of care: opportunities and challenges. (2011) (83)
Pre-morbid body mass index and mortality after incident heart failure: the ARIC Study. (2014) (82)
Comparison by meta-analysis of mortality after isolated coronary artery bypass grafting in women versus men. (2013) (80)
AHA Statistical Update Heart Disease and Stroke Statistics — 2015 Update A Report From the American Heart Association WRITING GROUP MEMBERS (2010) (79)
Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study. (2017) (77)
The Use of Sex-Specific Factors in the Assessment of Women’s Cardiovascular Risk (2020) (77)
Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement (2022) (75)
Effect of omega-3 fatty acids on cardiovascular outcomes: A systematic review and meta-analysis (2021) (74)
Continuity of care and outpatient management for patients with and at high risk for cardiovascular disease during the COVID-19 pandemic: A scientific statement from the American Society for Preventive Cardiology (2020) (73)
Lipoprotein abnormalities in South Asians and its association with cardiovascular disease: Current state and future directions. (2016) (70)
Frequency and practice-level variation in inappropriate aspirin use for the primary prevention of cardiovascular disease: insights from the National Cardiovascular Disease Registry's Practice Innovation and Clinical Excellence registry. (2015) (69)
Cost-Related Medication Nonadherence in Adults With Atherosclerotic Cardiovascular Disease in the United States, 2013 to 2017. (2019) (69)
A genetic risk score based on direct associations with coronary heart disease improves coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC), but not in the Rotterdam and Framingham Offspring, Studies. (2012) (67)
Preoperative statin therapy is not associated with a decrease in the incidence of postoperative atrial fibrillation in patients undergoing cardiac surgery. (2008) (67)
Association of Patient Perceptions of Cardiovascular Risk and Beliefs on Statin Drugs With Racial Differences in Statin Use: Insights From the Patient and Provider Assessment of Lipid Management Registry (2018) (66)
Subclinical changes in serum creatinine and mortality after coronary artery bypass grafting. (2012) (66)
Life's Simple 7 and Incident Heart Failure: The Multi‐Ethnic Study of Atherosclerosis (2017) (64)
Provider understanding of the 2013 ACC/AHA cholesterol guideline. (2016) (62)
Relationship between circulating levels of RANTES (regulated on activation, normal T-cell expressed, and secreted) and carotid plaque characteristics: the Atherosclerosis Risk in Communities (ARIC) Carotid MRI Study. (2011) (60)
Prosthesis-patient mismatch affects long-term survival after mechanical valve replacement. (2008) (59)
Cardiovascular Biomarkers and Subclinical Brain Disease in the Atherosclerosis Risk in Communities Study (2013) (59)
Prognostic significance of hyponatremia among ambulatory patients with heart failure and preserved and reduced ejection fractions. (2014) (58)
Ten things to know about ten cardiovascular disease risk factors (2021) (57)
Trends and Outcomes of Off-label Use of Transcatheter Aortic Valve Replacement: Insights From the NCDR STS/ACC TVT Registry (2017) (57)
Provider Type and Quality of Outpatient Cardiovascular Disease Care: Insights From the NCDR PINNACLE Registry. (2015) (56)
Association of gender with morbidity and mortality after isolated coronary artery bypass grafting. A propensity score matched analysis. (2013) (56)
Ceruloplasmin and Heart Failure in the Atherosclerosis Risk in Communities Study (2013) (55)
Comparative effectiveness of outpatient cardiovascular disease and diabetes care delivery between advanced practice providers and physician providers in primary care: Implications for care under the Affordable Care Act. (2016) (55)
Frequency and correlates of treatment intensification for elevated cholesterol levels in patients with cardiovascular disease. (2011) (54)
Mobile Health (mHealth) Technology for the Management of Hypertension and Hyperlipidemia: Slow Start but Loads of Potential (2017) (54)
Is High‐Intensity Statin Therapy Associated With Lower Statin Adherence Compared With Low‐ to Moderate‐Intensity Statin Therapy? Implications of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guidelines (2014) (53)
Clinical implications of JUPITER (Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin) in a U.S. population insights from the ARIC (Atherosclerosis Risk in Communities) study. (2009) (53)
Novel markers of inflammation in atherosclerosis (2008) (52)
Dyslipidemia, Coronary Artery Calcium, and Incident Atherosclerotic Cardiovascular DiseaseClinical Perspective (2014) (52)
Patients with severe chronic kidney disease benefit from early revascularization after acute coronary syndrome. (2013) (51)
Use of high-intensity statins for patients with atherosclerotic cardiovascular disease in the Veterans Affairs Health System: Practice impact of the new cholesterol guidelines. (2016) (50)
Financial Hardship From Medical Bills Among Nonelderly U.S. Adults With Atherosclerotic Cardiovascular Disease. (2019) (49)
Lipid management in contemporary community practice: Results from the Provider Assessment of Lipid Management (PALM) Registry (2017) (48)
Patient–Provider Communication and Health Outcomes Among Individuals With Atherosclerotic Cardiovascular Disease in the United States: Medical Expenditure Panel Survey 2010 to 2013 (2017) (47)
Institutional, provider, and patient correlates of low-density lipoprotein and non-high-density lipoprotein cholesterol goal attainment according to the Adult Treatment Panel III guidelines. (2011) (46)
Statin prescription rates and their facility-level variation in patients with peripheral artery disease and ischemic cerebrovascular disease: Insights from the Department of Veterans Affairs (2018) (45)
Frequency and practice-level variation in inappropriate and nonrecommended prasugrel prescribing: insights from the NCDR PINNACLE registry. (2014) (43)
Variants in the APOA5 gene region and the response to combination therapy with statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemia. (2011) (42)
Preoperative statin therapy decreases risk of postoperative renal insufficiency. (2010) (42)
Percutaneous coronary intervention vs. coronary artery bypass graft surgery for unprotected left main coronary artery disease in the drug-eluting stents era--an aggregate data meta-analysis of 11,148 patients. (2013) (41)
Relation of cholesterol and lipoprotein parameters with carotid artery plaque characteristics: the Atherosclerosis Risk in Communities (ARIC) carotid MRI study. (2011) (41)
Statin Use and Its Facility‐Level Variation in Patients With Diabetes: Insight From the Veterans Affairs National Database (2016) (41)
Genetics of Familial Hypercholesterolemia (2015) (40)
Therapeutic Inertia in Cardiovascular Disease Prevention: Time to Move the Bar. (2019) (40)
Adherence to cardiovascular medications in the South Asian population: A systematic review of current evidence and future directions. (2015) (39)
Elevated interleukin levels are associated with higher severity and mortality in COVID 19 – A systematic review, meta-analysis, and meta-regression (2020) (39)
Estimation of Eligibility for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors and Associated Costs Based on the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk): Insights From the Department of Veterans Affairs. (2017) (38)
Outcomes of preoperative angiotensin-converting enzyme inhibitor therapy in patients undergoing isolated coronary artery bypass grafting. (2012) (37)
Usefulness of single nucleotide polymorphism in chromosome 4q25 to predict in-hospital and long-term development of atrial fibrillation and survival in patients undergoing coronary artery bypass grafting. (2011) (37)
BNP and obesity in acute decompensated heart failure with preserved vs. reduced ejection fraction: The Atherosclerosis Risk in Communities Surveillance Study. (2017) (37)
Life's Simple 7 and the risk of atrial fibrillation: The Multi-Ethnic Study of Atherosclerosis. (2018) (37)
Short-Term Global Cardiovascular Disease Risk Prediction in Older Adults. (2018) (36)
Statin Use and Adverse Effects Among Adults >75 Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) Registry (2018) (36)
Correlation between apoptotic endothelial microparticles and serum interleukin-6 and C-reactive protein in healthy men. (2005) (36)
Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association (2023) (36)
Racial and Geographic Disparities in Internet Use in the U.S. Among Patients With Hypertension or Diabetes: Implications for Telehealth in the Era of COVID-19 (2020) (36)
Practice-Level Variation in Statin Use Among Patients With Diabetes: Insights From the PINNACLE Registry. (2016) (35)
Lipoprotein(a) levels and risk of cardiovascular disease events in individuals with diabetes mellitus or prediabetes: The Atherosclerosis Risk in Communities study. (2019) (35)
Favorable Cardiovascular Risk Profile Is Associated With Lower Healthcare Costs and Resource Utilization: The 2012 Medical Expenditure Panel Survey (2016) (35)
High-Sensitivity Troponin T and Cardiovascular Events in Systolic Blood Pressure Categories: Atherosclerosis Risk in Communities Study (2015) (35)
Burden and Consequences of Financial Hardship From Medical Bills Among Nonelderly Adults With Diabetes Mellitus in the United States (2020) (35)
Risk Factor Optimization and Guideline-Directed Medical Therapy in US Veterans With Peripheral Arterial and Ischemic Cerebrovascular Disease Compared to Veterans With Coronary Heart Disease. (2016) (35)
Meta-Analysis of Catheter Directed Ultrasound-Assisted Thrombolysis in Pulmonary Embolism. (2019) (35)
Secondary Prevention for Atherosclerotic Cardiovascular Disease: Comparing Recent US and European Guidelines on Dyslipidemia. (2020) (35)
High‐Sensitivity C‐Reactive Protein Discordance With Atherogenic Lipid Measures and Incidence of Atherosclerotic Cardiovascular Disease in Primary Prevention: The ARIC Study (2020) (34)
Isolated coronary artery bypass grafting in obese individuals: a propensity matched analysis of outcomes. (2011) (34)
Estimation of Eligibility for PCSK9 Inhibitors and Associated Costs Based on the FOURIER Trial: Insights from the Department of Veterans Affairs (2017) (33)
Associations of Lipoprotein(a) Levels With Incident Atrial Fibrillation and Ischemic Stroke: The ARIC (Atherosclerosis Risk in Communities) Study (2017) (32)
Influence of Cardiovascular Risk Communication Tools and Presentation Formats on Patient Perceptions and Preferences (2018) (32)
Independent Association of Lipoprotein(a) and Coronary Artery Calcification With Atherosclerotic Cardiovascular Risk. (2022) (32)
Assessment of Coronary Artery Calcium Scoring to Guide Statin Therapy Allocation According to Risk-Enhancing Factors: The Multi-Ethnic Study of Atherosclerosis. (2021) (32)
Triglycerides and ASCVD Risk Reduction: Recent Insights and Future Directions (2020) (32)
Variation and Disparities in Awareness of Myocardial Infarction Symptoms Among Adults in the United States (2019) (31)
Redefining myocardial infarction: what is new in the ESC/ACCF/AHA/WHF Third Universal Definition of myocardial infarction? (2013) (31)
Correction to: 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (2019) (30)
Variation in Lipid-Lowering Therapy Use in Patients With Low-Density Lipoprotein Cholesterol ≥190 mg/dL: Insights From the National Cardiovascular Data Registry–Practice Innovation and Clinical Excellence Registry (2018) (30)
Graves' disease and pulmonary hypertension: report of 2 cases. (2003) (30)
Premature Coronary Heart Disease in South Asians: Burden and Determinants (2018) (30)
Omega-3 Fatty Acid and Cardiovascular Outcomes: Insights From Recent Clinical Trials (2019) (30)
Segmental analysis of carotid arterial strain using speckle-tracking. (2011) (29)
Combating non-communicable diseases: potentials and challenges for community health workers in a digital age, a narrative review of the literature (2019) (29)
Lipoprotein(a) and Family History Predict Cardiovascular Disease Risk. (2020) (29)
Barriers to non-HDL cholesterol goal attainment by providers. (2011) (29)
Using Mobile Health (mHealth) Technology in the Management of Diabetes Mellitus, Physical Inactivity, and Smoking (2017) (29)
Absence of Coronary Artery Calcification in Middle Aged Familial Hypercholesterolemia Patients Without Atherosclerotic Cardiovascular Disease. (2019) (28)
Economic Impact of Moderate‐Vigorous Physical Activity Among Those With and Without Established Cardiovascular Disease: 2012 Medical Expenditure Panel Survey (2016) (28)
Association of Income Disparities with Patient-Reported Healthcare Experience (2019) (28)
Treating Chronically Ill People with Diabetes Mellitus with Limited Life Expectancy: Implications for Performance Measurement (2012) (28)
Novel emerging therapies in atherosclerosis targeting lipid metabolism (2020) (28)
Chromosome 9p21 single nucleotide polymorphisms are not associated with recurrent myocardial infarction in patients with established coronary artery disease. (2012) (28)
Stroke in young adults: Current trends, opportunities for prevention and pathways forward (2020) (28)
Temporal Trends in Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting: Insights From the Washington Cardiac Care Outcomes Assessment Program (2020) (28)
Oral Antiplatelet Therapy After Acute Coronary Syndrome: A Review. (2021) (27)
Impact of clinical complexity on the quality of diabetes care. (2012) (27)
Comparison by meta-analysis of percutaneous coronary intervention versus coronary artery bypass grafting in patients with a mean age of ≥70 years. (2013) (27)
Evaluating Periodontal Treatment to Prevent Cardiovascular Disease: Challenges and Possible Solutions (2017) (27)
Preventive Cardiology as a Subspecialty of Cardiovascular Medicine: JACC Council Perspectives. (2019) (27)
Effect of Long-Term Periodontal Care on Hemoglobin A1c in Type 2 Diabetes (2016) (27)
Eligibility for statin therapy according to new cholesterol guidelines and prevalent use of medication to lower lipid levels in an older US Cohort: the Atherosclerosis Risk in Communities Study Cohort. (2015) (27)
Health Care Resource Utilization for Outpatient Cardiovascular Disease and Diabetes Care Delivery Among Advanced Practice Providers and Physician Providers in Primary Care. (2017) (27)
Total cholesterol/HDL-cholesterol ratio discordance with LDL-cholesterol and non-HDL-cholesterol and incidence of atherosclerotic cardiovascular disease in primary prevention: The ARIC study (2020) (26)
Automatic quantification of muscle volumes in magnetic resonance imaging scans of the lower extremities. (2011) (26)
Takotsubo cardiomyopathy, or broken-heart syndrome. (2007) (26)
Evaluation of Aspirin and Statin Therapy Use and Adherence in Patients With Premature Atherosclerotic Cardiovascular Disease (2020) (26)
Obesity: an independent predictor of in-hospital postoperative renal insufficiency among patients undergoing cardiac surgery? (2009) (26)
Making prescriptions “talk” to stroke and heart attack survivors to improve adherence: Results of a randomized clinical trial (The Talking Rx Study) (2018) (25)
Social Vulnerability and Premature Cardiovascular Mortality Among US Counties, 2014 to 2018 (2021) (25)
Surfing the Waves of the COVID-19 Pandemic As A Cardiovascular Clinician. (2020) (25)
Sociodemographic Disparities in Influenza Vaccination Among Adults With Atherosclerotic Cardiovascular Disease in the United States. (2020) (25)
Burden of Catastrophic Health Expenditures for Acute Myocardial Infarction and Stroke Among Uninsured in the United States. (2017) (25)
Cor triatriatum dexter. (2007) (24)
The Effect of Lipid Modification on Peripheral Artery Disease after Endovascular Intervention Trial (ELIMIT). (2013) (24)
Age-Stratified Sex Disparities in Care and Outcomes in Patients with ST-elevation Myocardial Infarction. (2020) (24)
Persistent socioeconomic disparities in cardiovascular risk factors and health in the United States: Medical Expenditure Panel Survey 2002-2013. (2018) (24)
A novel mutation in the ABCA1 gene causing an atypical phenotype of Tangier disease. (2013) (23)
Ticagrelor Use in Acute Myocardial Infarction: Insights From the National Cardiovascular Data Registry (2018) (23)
Impact of Selection Bias on Estimation of Subsequent Event Risk (2017) (23)
Myocardial Injury, Obesity, and the Obesity Paradox: The ARIC Study. (2017) (23)
Guideline‐Directed Medication Use in Patients With Heart Failure With Reduced Ejection Fraction in India: American College of Cardiology's PINNACLE India Quality Improvement Program (2016) (22)
Promise and Perils of Telehealth in the Current Era (2021) (22)
Disease-Specific Excess Mortality During the COVID-19 Pandemic: An Analysis of Weekly US Death Data for 2020. (2021) (22)
Lipoprotein(a) and cardiovascular disease: current state and future directions for an enigmatic lipoprotein. (2018) (22)
Prevalence and Management of Symptoms Associated With Statin Therapy in Community Practice: Insights From the PALM (Patient and Provider Assessment of Lipid Management) Registry (2018) (22)
The Role of Intracoronary Plaque Imaging with Intravascular Ultrasound, Optical Coherence Tomography, and Near-Infrared Spectroscopy in Patients with Coronary Artery Disease (2016) (21)
Is 2015 the Primetime Year for Prehypertension? Prehypertension: A Cardiovascular Risk Factor or Simply a Risk Marker? (2015) (21)
Coronary Artery Calcification, Statin Use and Long-Term Risk of Atherosclerotic Cardiovascular Disease Events (from the Multi-Ethnic Study of Atherosclerosis). (2019) (21)
Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events (2019) (21)
Variability and persistence of aspirin response in lower extremity peripheral arterial disease patients. (2011) (21)
Clinical Outcomes of Percutaneous Interventions in Saphenous Vein Grafts Using Drug‐Eluting Stents Compared to Bare‐Metal Stents: A Comprehensive Meta‐Analysisof All Randomized Clinical Trials (2012) (21)
Association between traditional cholesterol parameters, lipoprotein particle concentration, novel biomarkers and carotid plaques in retired National Football League players. (2012) (21)
Frequency of Statin Use in Patients With Low-Density Lipoprotein Cholesterol ≥190 mg/dl from the Veterans Affairs Health System. (2018) (21)
The use of structured data elements to identify ASCVD patients with statin-associated side effects: Insights from the Department of Veterans Affairs. (2019) (20)
Association between statins and infections after coronary artery bypass grafting. (2013) (20)
Does preoperative statin therapy improve outcomes in patients undergoing isolated cardiac valve surgery? (2008) (20)
Utilization Rates of SGLT2 Inhibitors and GLP-1 Receptor Agonists and Their Facility-Level Variation Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes: Insights From the Department of Veterans Affairs. (2022) (20)
The association of lipoprotein(a) with incident heart failure hospitalization: Atherosclerosis Risk in Communities study. (2017) (20)
Design and rationale for the Patient and Provider Assessment of Lipid Management (PALM) registry. (2015) (20)
Recreational substance use among patients with premature atherosclerotic cardiovascular disease (2021) (20)
National Trends in Nonstatin Use and Expenditures Among the US Adult Population From 2002 to 2013: Insights From Medical Expenditure Panel Survey (2018) (19)
Primary and Secondary Prevention of Cardiovascular Disease in Patients with Chronic Kidney Disease (2019) (19)
Apolipoproteins do not add prognostic information beyond lipoprotein cholesterol measures among individuals with obesity and insulin resistance syndromes: the ARIC study (2014) (19)
Social Determinants of Health and Cardiovascular Disease: Current State and Future Directions Towards Healthcare Equity (2021) (19)
Aspirin for the Primary Prevention of Cardiovascular Disease: In Need of Clarity (2016) (19)
Neck Circumference Is Not Associated With Subclinical Atherosclerosis in Retired National Football League Players (2014) (19)
Frequency of Attainment of Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol Goals in Cardiovascular Clinical Practice (from the National Cardiovascular Data Registry PINNACLE Registry). (2015) (19)
Off‐Pump Coronary Artery Grafting in Patients with Left Main Coronary Artery Disease (2005) (19)
Clinical and Economic Burden of Stroke Among Young, Midlife, and Older Adults in the United States, 2002-2017 (2021) (19)
Efficacy of Angiotensin-Converting Enzyme Inhibitors and Angiotensin-Receptor Blockers in Coronary Artery Disease without Heart Failure in the Modern Statin Era: a Meta-Analysis of Randomized-Controlled Trials (2016) (19)
Temporal Trends in E-Cigarette Use Among U.S. Adults: Behavioral Risk Factor Surveillance System, 2016 to 2018. (2020) (19)
Trends in Ideal Cardiovascular Health Metrics Among Employees of a Large Healthcare Organization (from the Baptist Health South Florida Employee Study). (2016) (19)
Trends in U.S. Ambulatory Cardiovascular Care 2013 to 2017: JACC Review Topic of the Week. (2020) (18)
Improving adherence to cardiovascular guidelines: realistic transition from paper to patient (2020) (18)
Correlates of repeat lipid testing in patients with coronary heart disease. (2013) (18)
Association between high-sensitivity troponin T and cardiovascular risk in individuals with and without metabolic syndrome: The ARIC study (2017) (18)
Anti-Hypertensive Medication Use, Soluble Receptor for Glycation End Products and Risk of Pancreatic Cancer in the Women’s Health Initiative Study (2018) (18)
Very High-Risk ASCVD and Eligibility for Nonstatin Therapies Based on the 2018 AHA/ACC Cholesterol Guidelines. (2019) (17)
Non-high-density lipoprotein cholesterol reporting and goal attainment in primary care. (2012) (17)
Clinical pharmacist understanding of the 2013 American College of Cardiology/American Heart Association cholesterol guideline. (2017) (17)
Socio-economic inequalities in hypertension burden and cascade of services: nationwide cross-sectional study in Nepal (2019) (17)
Variation in the Use of Warfarin and Direct Oral Anticoagulants in Atrial Fibrillation and Associated Cost Implications. (2019) (17)
Pet Ownership and Cardiovascular Health in the US General Population. (2020) (17)
Cardio-metabolic disease risk factors among South Asian labour migrants to the Middle East: a scoping review and policy analysis (2019) (17)
Burden of cardiovascular risk factors and disease in five Asian groups in Catalonia: a disaggregated, population-based analysis of 121 000 first-generation Asian immigrants. (2021) (17)
Revascularization Practices and Outcomes in Patients With Multivessel Coronary Artery Disease Who Presented With Acute Myocardial Infarction and Cardiogenic Shock in the US, 2009-2018. (2020) (17)
How low is safe? The frontier of very low (<30 mg/dL) LDL cholesterol. (2021) (17)
Cardiovascular risk and complications associated with COVID-19. (2020) (17)
Case-based educational intervention to assess change in providers' knowledge and attitudes towards the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline. (2016) (17)
The relationship between cardiorespiratory fitness, cardiovascular risk factors and atherosclerosis. (2020) (17)
Eligibility and Cost for Icosapent Ethyl Based on the REDUCE-IT Trial. (2019) (17)
A Roadmap on the Prevention of Cardiovascular Disease Among People Living With Diabetes. (2019) (16)
Revascularization improves mortality in elderly patients with acute myocardial infarction complicated by cardiogenic shock. (2014) (16)
Associations between particulate matter air pollution, presence and progression of subclinical coronary and carotid atherosclerosis: A systematic review. (2020) (16)
Obesity and the paradox of mortality and heart failure hospitalization in heart failure with preserved ejection fraction (2020) (16)
Atherosclerotic Cardiovascular Disease, Cancer, and Financial Toxicity Among Adults in the United States (2021) (16)
Association Between Sociodemographic Determinants and Disparities in Stroke Symptom Awareness Among US Young Adults (2020) (16)
Antiplatelet Management for Coronary Heart Disease: Advances and Challenges (2016) (16)
Association of Clinician Knowledge and Statin Beliefs With Statin Therapy Use and Lipid Levels (A Survey of US Practice in the PALM Registry). (2019) (16)
Plasma dehydroepiandrosterone sulfate and cardiovascular disease risk in older men and women. (2020) (16)
Association of Body Mass Index and Waist Circumference with Subclinical Atherosclerosis in Retired NFL Players (2014) (16)
Cardiovascular Disease Performance Measures in the Outpatient Setting in India: Insights From the American College of Cardiology’s PINNACLE India Quality Improvement Program (PIQIP) (2015) (16)
Biomarkers and degree of atherosclerosis are independently associated with incident atherosclerotic cardiovascular disease in a primary prevention cohort: The ARIC study. (2016) (16)
Correction to: 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (2019) (15)
Determinants of Influenza Vaccine Uptake in Patients With Cardiovascular Disease and Strategies for Improvement (2021) (15)
Fish Consumption and Cardiovascular Health: A Systematic Review. (2021) (15)
High-density lipoprotein cholesterol and causes of death in chronic kidney disease. (2018) (15)
Association of low-density lipoprotein pattern with mortality after myocardial infarction: Insights from the TRIUMPH study. (2017) (15)
Cumulative Burden of Financial Hardship From Medical Bills Across the Spectrum of Diabetes Mellitus and Atherosclerotic Cardiovascular Disease Among Non‐Elderly Adults in the United States (2020) (14)
Association of insurance type with receipt of oral anticoagulation in insured patients with atrial fibrillation: A report from the American College of Cardiology NCDR PINNACLE registry (2018) (14)
The 9p21 genetic variant is additive to carotid intima media thickness and plaque in improving coronary heart disease risk prediction in white participants of the Atherosclerosis Risk in Communities (ARIC) Study. (2010) (14)
Associations Between Carotid Artery Plaque Burden, Plaque Characteristics, and Cardiovascular Events: The ARIC Carotid Magnetic Resonance Imaging Study. (2020) (14)
Sex-Related Disparities in Cardiovascular Health Care Among Patients With Premature Atherosclerotic Cardiovascular Disease. (2021) (14)
Subsequent Event Risk in Individuals With Established Coronary Heart Disease (2019) (14)
Practice-level variation in statin use and low-density lipoprotein cholesterol control in the United States: Results from the Patient and Provider Assessment of Lipid Management (PALM) registry. (2019) (14)
Association of NT-ProBNP, Blood Pressure, and Cardiovascular Events: The ARIC Study. (2021) (14)
Non-high-density lipoprotein cholesterol calculation and goal awareness among physicians-in-training. (2012) (14)
Trends and Predictors of Transcatheter Aortic Valve Implantation Related In-Hospital Mortality (From a National Inpatient Sample Database). (2020) (14)
Application of speckle-tracking in the evaluation of carotid artery function in subjects with hypertension and diabetes. (2013) (14)
Temporal Trends in Care and Outcomes of Patients Receiving Fibrinolytic Therapy Compared to Primary Percutaneous Coronary Intervention: Insights From the Get With The Guidelines Coronary Artery Disease (GWTG‐CAD) Registry (2015) (14)
Lipid-Lowering Biotechnological Drugs: from Monoclonal Antibodies to Antisense Therapies—a Clinical Perspective (2020) (14)
Associations Between High-Density Lipoprotein Particles and Ischemic Events by Vascular Domain, Sex, and Ethnicity (2020) (13)
Identifying Occupational Performance Barriers of Stroke Survivors: Utilization of a Home Assessment (2012) (13)
Targeting Inflammation After Myocardial Infarction (2020) (13)
Association between frequency of primary care provider visits and evidence-based statin prescribing and statin adherence: Findings from the Veterans Affairs system. (2019) (13)
Premature Atherosclerotic Cardiovascular Disease: What Have We Learned Recently? (2020) (13)
Effectiveness of NPs and PAs in managing diabetes and cardiovascular disease (2018) (13)
Switching warfarin to direct oral anticoagulants in atrial fibrillation: Insights from the NCDR PINNACLE registry (2020) (13)
The role of lipoprotein-associated phospholipase A2 as a marker for atherosclerosis (2007) (13)
LPL gene variants affect apoC-III response to combination therapy of statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemia[S] (2012) (13)
Acute Coronary Syndromes: Unstable Angina and Non-ST Elevation Myocardial Infarction. (2016) (13)
Highlights from Selected Cardiovascular Disease Prevention Studies Presented at the 2019 European Society of Cardiology Congress (2019) (13)
Statin Prescription Rates, Adherence, and Associated Clinical Outcomes Among Women with PAD and ICVD (2020) (13)
The 2018 Cholesterol Management Guidelines: Topics in Secondary ASCVD Prevention Clinicians Need to Know (2019) (13)
Heterogeneity in cardio-metabolic risk factors and atherosclerotic cardiovascular disease among Asian groups in the United States (2021) (13)
Relation between playing position and coronary artery calcium scores in retired National Football League players. (2014) (12)
Autoimmune rheumatic diseases and premature atherosclerotic cardiovascular disease: An analysis from the VITAL (Veterans wIth premaTure AtheroscLerosis) registry. (2020) (12)
Lipoprotein(a) and ethnicities. (2022) (12)
Prevalence of ideal cardiovascular health metrics in children & adolescents: A systematic review (2016) (12)
Heart Association Task Force on Practice Guidelines Undergoing Noncardiac Surgery: A Report of the American College of Cardiology/American ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Perioperative Beta Blockade in Noncardiac Surgery: A Systematic Review fo (2014) (12)
Prescription Patterns of Clopidogrel, Prasugrel, and Ticagrelor After Percutaneous Coronary Intervention With Stent Implantation (from the NCDR PINNACLE Registry). (2019) (12)
Using a tailored health information technology- driven intervention to improve health literacy and medication adherence in a Pakistani population with vascular disease (Talking Rx) – study protocol for a randomized controlled trial (2016) (12)
Implications of the Eighth Joint National Committee Guidelines for the Management of High Blood Pressure for Aging Adults: Atherosclerosis Risk in Communities Study (2015) (12)
Revisiting the economic efficiencies of observation units. (2015) (12)
Left main coronary artery stenosis: factors predicting cardiac events in patients awaiting coronary surgery. (2006) (12)
Mushroom Consumption and Cardiovascular Health: A Systematic Review. (2020) (12)
Cardiovascular Disease Prevention: Training Opportunities, the Challenges, and Future Directions (2018) (12)
Real-time co-registration using novel ultrasound technology: ex vivo validation and in vivo applications. (2011) (12)
Screening and advanced lipid phenotyping in familial hypercholesterolemia: The Very Large Database of Lipids Study-17 (VLDL-17). (2015) (12)
The Use of Risk-Enhancing Factors to Personalize ASCVD Risk Assessment: Evidence and Recommendations from the 2018 AHA/ACC Multi-Society Cholesterol Guidelines (2019) (12)
Renin-angiotensin system blocker discontinuation and adverse outcomes in chronic kidney disease. (2020) (12)
Impact of Lipid Monitoring on Treatment Intensification of Cholesterol Lowering Therapies (from the Veterans Affairs Healthcare System). (2019) (12)
Highlights from Studies in Cardiovascular Disease Prevention Presented at the Digital 2020 European Society of Cardiology Congress: Prevention Is Alive and Well (2020) (12)
Favorable cardiovascular risk factor profile is associated with lower healthcare expenditure and resource utilization among adults with diabetes mellitus free of established cardiovascular disease: 2012 Medical Expenditure Panel Survey (MEPS). (2017) (12)
Facility-Level Variations in Kidney Disease Care among Veterans with Diabetes and CKD. (2018) (12)
Does clinician‐reported lipid guideline adoption translate to guideline‐adherent care? An evaluation of the Patient and Provider Assessment of Lipid Management (PALM) registry (2018) (12)
Gender disparities in cardiovascular care access and delivery in India: Insights from the American College of Cardiology's PINNACLE India Quality Improvement Program (PIQIP). (2015) (12)
Association Between Lipid Testing and Statin Adherence in the Veterans Affairs Health System. (2019) (11)
Association Between Modifiable Risk Factors and Pharmaceutical Expenditures Among Adults With Atherosclerotic Cardiovascular Disease in the United States: 2012–2013 Medical Expenditures Panel Survey (2017) (11)
Measurement of Low‐Density Lipoprotein Cholesterol Levels in Primary and Secondary Prevention Patients: Insights From the PALM Registry (2018) (11)
Medical Therapy Utilization and Long-Term Outcomes Following Percutaneous Coronary Intervention: Five-Year Results From the Veterans Affairs Clinical Assessment, Reporting, and Tracking System Program. (2019) (11)
Four Cases of Cholesterol Management Informed by the 2018 American Heart Association/American College of Cardiology Multisociety Guideline on the Management of Blood Cholesterol. (2019) (11)
Applicability and Cost Implications for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Based on the ODYSSEY Outcomes Trial. (2019) (11)
Non-traditional risk factors and the risk of myocardial infarction in the young in the US population-based cohort (2020) (11)
Spotlight on Icosapent Ethyl for Cardiovascular Risk Reduction: Evidence to Date (2020) (10)
Cholesterol Insights and Controversies From the UK Biobank Study. (2019) (10)
Lipoprotein (a): Recent Updates on a Unique Lipoprotein (2021) (10)
Treatment of AF in American Indians and Alaska Natives: Insights From the NCDR PINNACLE-AF Registry. (2020) (10)
Effects of the 2021 CKD-EPI Creatinine eGFR Equation among a National US Veteran Cohort. (2021) (10)
Intensity of Lipid Lowering With Statin Therapy in Patients With Cerebrovascular Disease Versus Coronary Artery Disease: Insights from the PALM Registry (2019) (10)
ApoB, small-dense LDL-C, Lp(a), LpPLA2 activity, and cognitive change (2019) (10)
Favorable Modifiable Cardiovascular Risk Profile Is Associated With Lower Healthcare Costs Among Cancer Patients: The 2012–2013 Medical Expenditure Panel Survey (2018) (10)
Implications for Ezetimibe Therapy Use Based on IMPROVE-IT Criteria. (2015) (10)
Racial and Geographic Disparities in Internet Use in the United States Among Patients with Atherosclerotic Cardiovascular Disease (2020) (10)
Incidental diagnosis of interrupted aortic arch in a 72-year-old man. (2009) (10)
Low-Density Lipoprotein Cholesterol: Is 160 the New 190? (2018) (10)
Factors associated with rhythm control treatment decisions in patients with atrial fibrillation—Insights from the NCDR PINNACLE registry (2017) (10)
Postprandial effects on arterial stiffness parameters in healthy young adults (2015) (10)
Highlights of Studies in Cardiovascular Disease Prevention Presented at the 2020 American College of Cardiology Annual Scientific Session (2020) (10)
Implications of the FDA approval of PCSK9 inhibitors and FOURIER results for contemporary cardiovascular practice: An NCDR Research to Practice (R2P) project (2018) (10)
Determinants of Incident Atherosclerotic Cardiovascular Disease Events Among Those With Absent Coronary Artery Calcium: Multi-Ethnic Study of Atherosclerosis. (2021) (10)
Medicare Eligibility and Physician Utilization Among Adults With Coronary Heart Disease and Stroke (2012) (10)
Adapting a club-based medication delivery strategy to a hypertension context: the CLUBMEDS Study in Nigeria (2019) (10)
Association of Blood Pressure Variability and Diuretics With Cardiovascular Events in Patients With Chronic Kidney Disease Stages 1-5. (2021) (10)
Major Randomized Clinical Trials in Cardiovascular Disease Prevention Presented at the 2019 American College of Cardiology Annual Scientific Session (2019) (10)
Shared Decisions: A Qualitative Study on Clinician and Patient Perspectives on Statin Therapy and Statin‐Associated Side Effects (2020) (10)
Epidemiologic studies targeting primary cardiovascular disease prevention in South Asia (2018) (10)
Social determinants of health and obesity: Findings from a national study of US adults (2022) (10)
Pathophysiological Mechanisms Underlying Excess Risk for Diabetes and Cardiovascular Disease in South Asians: The Perfect Storm. (2020) (9)
Racial disparities among Asian Americans with atrial fibrillation: An analysis from the NCDR® PINNACLE Registry. (2021) (9)
Calculations of Financial Incentives for Providers in a Pay-for-Performance Program: Manual Review Versus Data From Structured Fields in Electronic Health Records (2015) (9)
Has the "strength" of fish oil therapy been "reduced"? reconciling the results of REDUCE-IT and STRENGTH. (2021) (9)
CLEAR Serenity Trial: More Clarity for the Future of Bempedoic Acid in Patients Unable to Take Statins? (2019) (9)
Rare APOA5 promoter variants associated with paradoxical HDL cholesterol decrease in response to fenofibric acid therapy[S] (2013) (9)
Association between intensity of statin therapy and mortality in persons with chronic kidney disease. (2018) (9)
Case reports of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition nonresponse. (2018) (9)
Statins in the primary and secondary prevention of cardiovascular disease in women: facts and myths. (2013) (9)
Premature Atherosclerotic Cardiovascular Disease Risk Among Patients with Inflammatory Bowel Disease. (2021) (9)
Trends in Premature Mortality From Acute Myocardial Infarction in the United States, 1999 to 2019 (2021) (9)
Long-term clinical outcome of coronary artery stenting or coronary artery bypass grafting in patients with multiple-vessel disease. (2008) (9)
Coronary artery disease in the young in the US population-based cohort. (2020) (9)
Discordance Between Standard Equations for Determination of LDL Cholesterol in Patients With Atherosclerosis. (2022) (9)
Distribution of calcium volume, density, number, and type of coronary vessel with calcified plaque in South Asians in the US and other race/ethnic groups: The MASALA and MESA studies. (2020) (9)
Predictors of in-hospital mortality in patients with end-stage renal disease undergoing transcatheter aortic valve replacement: A nationwide inpatient sample database analysis. (2021) (9)
Rare LPL gene variants attenuate triglyceride reduction and HDL cholesterol increase in response to fenofibric acid therapy in individuals with mixed dyslipidemia. (2014) (9)
Racial and geographic disparities in influenza vaccination in the U.S. among individuals with atherosclerotic cardiovascular disease: Renewed importance in the setting of COVID-19 (2021) (9)
Management of type 2 diabetes in chronic kidney disease (2021) (8)
Trends in Characteristics and Outcomes of Hospitalized Young Patients Undergoing Coronary Artery Bypass Grafting in the United States, 2004 to 2018 (2021) (8)
Overview of Coronary Heart Disease Risk Initiatives in South Asia (2017) (8)
Coronavirus disease‐19 and cardiovascular disease: A risk factor or a risk marker? (2020) (8)
How to identify patients with vulnerable plaques (2008) (8)
Implications of cost-effectiveness analyses of lipid-lowering therapies: From the policy-maker's desk to the patient's bedside. (2019) (8)
Effect of increasing age on percutaneous coronary intervention vs coronary artery bypass grafting in older adults with unprotected left main coronary artery disease: A meta‐analysis and meta‐regression (2019) (8)
Burden of chronic kidney disease in the general population and high-risk groups in South Asia: A systematic review and meta-analysis (2021) (8)
One‐Year Outcomes Associated With Using Observation Services in Triaging Patients With Nonspecific Chest Pain (2014) (8)
The Fibrates Story - A Tepid End to a PROMINENT Drug. (2022) (8)
Soluble Angiotensin-Converting Enzyme 2, Cardiac Biomarkers, Structure, and Function, and Cardiovascular Events (From the Atherosclerosis Risk in Communities Study). (2021) (8)
Chromosome 9 p 21 Single Nucleotide Polymorphisms Are Not Associated With Recurrent Myocardial Infarction in Patients With Established Coronary Artery Disease (2012) (7)
Highlights from Studies Presented at the American Heart Association Scientific Session 2020: Navigating New Roads in Prevention (2021) (7)
Gender disparities in difficulty accessing healthcare and cost-related medication non-adherence: The CDC behavioral risk factor surveillance system (BRFSS) survey. (2021) (7)
Discordance: can we capitalize on it to better personalize atherosclerosis treatment? (2013) (7)
High‐Sensitive Troponin T, Natriuretic Peptide, and Cognitive Change (2019) (7)
Associations Between HDL Particles and Ischemic Events by Vascular Domain, Gender, and Ethnicity: A Pooled Cohort Analysis (2020) (7)
Association of Low-Density Lipoprotein Testing after an Atherosclerotic Cardiovascular Event with Subsequent Statin Adherence and Intensification. (2021) (7)
Hypertension guidelines and coronary artery calcification among South Asians: Results from MASALA and MESA (2021) (7)
Differential Lipid Response to Statins Is Associated With Variants in the BUD13–APOA5 Gene Region (2015) (7)
Meta‐analysis comparing valve‐in‐valve TAVR and redo‐SAVR in patients with degenerated bioprosthetic aortic valve (2021) (7)
Global think tank on the clinical considerations and management of lipoprotein(a): The top questions and answers regarding what clinicians need to know. (2022) (7)
Impact of Patient-Centered Medical Home Implementation on Diabetes Control in the Veterans Health Administration (2018) (7)
A simplified pathway to proprotein convertase subtilisin/kexin type 9 inhibitor prior authorization approval: A lipid clinic experience. (2017) (6)
Single nucleotide polymorphisms in cholesteryl ester transfer protein gene and recurrent coronary heart disease or mortality in patients with established atherosclerosis. (2013) (6)
The Association of Sleep Duration and Morbid Obesity in a Working Population: The Baptist Health South Florida Employee Study. (2017) (6)
Dyslipidemia and Cardiovascular Disease Prevention in South Asians: A Review and Discussion of Causes, Challenges and Management Strategies. (2021) (6)
Temporal Changes and Institutional Variation in Use of Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction With Multivessel Coronary Artery Disease in the United States: An NCDR Research to Practice Project. (2020) (6)
Applicability of the IMPROVE-IT Trial to Current Patients With Acute Coronary Syndrome: An NCDR Research to Practice Project (2017) (6)
Rescue Percutaneous Coronary Intervention for Graft Failure Immediately After Coronary Artery Bypass Grafting: Case Report and Review of Literature (2008) (6)
Lipid Management Guidelines from the Departments of Veteran Affairs and Defense: A Critique. (2016) (6)
The Association of Electronic Cigarette Use and the Subjective Domains of Physical and Mental Health: The Behavioral Risk Factor Surveillance System Survey (2020) (6)
National Population and Cost Implications of Treatment with Icosapentyl Ethyl in the United States: An Assessment Based on the REDUCE-IT trial (2018) (6)
Novel Therapies for Treating Familial Hypercholesterolemia (2013) (6)
Association between preoperative diuretic use and in-hospital outcomes after cardiac surgery. (2013) (6)
Association between lipoprotein associated phospholipase A2 mass and subclinical coronary and carotid atherosclerosis in Retired National Football League players. (2014) (6)
Effect of Long-Term Periodontal Care on Hemoglobin A 1 c in Type 2 Diabetes (2016) (6)
Meta-Analysis of Comparison of 5-Year Outcomes of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Unprotected Left Main Coronary Artery in the Era of Drug-eluting Stents. (2017) (6)
Impact of colchicine on pericardial inflammatory syndromes--an analysis of randomized clinical trials. (2012) (6)
A dataset to assess providers׳ knowledge and attitudes towards the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline (2016) (6)
Sex Differences in the Age of Diagnosis for Cardiovascular Disease and Its Risk Factors Among US Adults: Trends From 2008 to 2017, the Medical Expenditure Panel Survey (2020) (6)
Low levels of ideal cardiovascular health in a semi-urban population of Western Nepal: a population-based, cross-sectional study (2019) (6)
Applicability and Cost Implications for PCKS9 Inhibitors Based on the ODYSSEY Outcomes Trial: Insights from the Department of Veterans Affairs (2018) (6)
E-cigarette Use and Risk Behaviors among Lesbian, Gay, Bisexual, and Transgender Adults: The Behavioral Risk Factor Surveillance System (BRFSS) Survey (2020) (6)
The Interplay of the Global Atherosclerotic Cardiovascular Disease Risk Scoring and Cardiorespiratory Fitness for the Prediction of All-Cause Mortality and Myocardial Infarction: The Henry Ford ExercIse Testing Project (The FIT Project). (2019) (6)
Meditation and Cardiovascular Health in the US. (2020) (6)
Acute Aortic Valve Rupture From Infective Endocarditis After Transrectal Prostate Biopsy: A Call to Revise the AHA Guidelines for Prevention of Infective Endocarditis (2013) (6)
Prevalence of and Sociodemographic Disparities in Influenza Vaccination Among Adults With Diabetes in the United States (2020) (6)
Greater than expected reduction in low-density lipoprotein-cholesterol (LDL-C) with bempedoic acid in a patient with heterozygous familial hypercholesterolemia (HeFH). (2021) (5)
Association Between Omega-3 Fatty Acid Treatment and Atrial Fibrillation in Cardiovascular Outcome Trials: A Systematic Review and Meta-Analysis (2021) (5)
Patient-Perceived Versus Actual Risk of Cardiovascular Disease and Associated Willingness to Consider and Use Prevention Therapy. (2021) (5)
Efficacy and safety for the achievement of guideline-recommended lower low-density lipoprotein cholesterol levels: a systematic review and meta-analysis. (2020) (5)
Statin Eligibility, Coronary Artery Calcium, and Subsequent Cardiovascular Events According to the 2016 United States Preventive Services Task Force (USPSTF) Statin Guidelines: MESA (Multi‐Ethnic Study of Atherosclerosis) (2018) (5)
What is new in the 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic risk in adults? (2014) (5)
Relation Between Cardiology Follow-Up Visits, Evidence-Based Statin Prescribing, and Statin Adherence (from the Veterans Affairs Health Care System). (2019) (5)
Beliefs, risk perceptions, and lipid management among patients with and without diabetes: Results from the PALM registry. (2020) (5)
2018 Cholesterol Guidelines: Key Topics in Primary Prevention (2019) (5)
PCSK9 Inhibitors Prior Authorization. (2019) (5)
Magnetic Resonance Venous Volume Measurements in Peripheral Artery Disease (from ELIMIT). (2016) (5)
Nondietary Cardiovascular Health Metrics With Patient Experience and Loss of Productivity Among US Adults Without Cardiovascular Disease: The Medical Expenditure Panel Survey 2006 to 2015 (2020) (5)
Prevalence and predictors of cost-related medication nonadherence in individuals with cardiovascular disease: Results from the Behavioral Risk Factor Surveillance System (BRFSS) survey. (2021) (5)
American College of Cardiology (ACC)’s PINNACLE India Quality Improvement Program (PIQIP)—Inception, progress and future direction: A report from the PIQIP Investigators (2016) (5)
Prevalence of cardiovascular risk factors in a nationally representative adult population with inflammatory bowel disease without atherosclerotic cardiovascular disease (2021) (5)
Associations Between Lipoprotein(a) Levels and Cardiovascular Outcomes in African Americans and Caucasians: The Atherosclerosis Risk in Communities (ARIC) Study (2011) (5)
Highlights from Studies Presented at the Virtual American College of Cardiology Scientific Sessions 2021: Staying Updated with the Latest Advancements in Prevention (2021) (5)
Popular Media and Cardiovascular Medicine: “with Great Power There Must Also Come Great Responsibility” (2019) (5)
Omega‐3 Fatty Acids (Fish Oil) Supplementation and Albuminuria: Not a Slam Dunk (2017) (5)
Facility‐level variation in diabetes and blood pressure control in patients with diabetes: Findings from the Veterans Affairs national database (2017) (5)
Association of PCSK9 Variants with the Risk of Atherosclerotic Cardiovascular Disease and Variable Responses to PCSK9 Inhibitor Therapy. (2021) (5)
Sex differences in the association between cardiovascular diseases and dementia subtypes: a prospective analysis of 464,616 UK Biobank participants (2022) (5)
Highlights of Cardiovascular Disease Studies Presented at the 2021 American Heart Association Scientific Sessions (2022) (5)
Incorporating Guideline Adherence and Practice Implementation Issues into the Design of Decision Support for Beta-Blocker Titration for Heart Failure (2018) (5)
Facility-Level Variation in Reported Statin-Associated Side Effects Among Patients with Atherosclerotic Cardiovascular Disease—Perspective from the Veterans Affair Healthcare System (2021) (5)
Social Determinants of Health and Comorbidities Among Individuals with Atherosclerotic Cardiovascular Disease: The Behavioral Risk Factor Surveillance System Survey. (2021) (5)
Prevalence and predictors of premature coronary heart disease among Asians in the United States: A National Health Interview Survey Study. (2022) (5)
Clinical significance, angiographic characteristics, and short-term outcomes in 30 patients with early coronary artery graft failure (2009) (5)
Highlights of Cardiovascular Disease Studies Presented at the 2021 European Society of Cardiology Congress (2021) (5)
Cardiovascular Disease Prevention in Focus: Highlights from the 2019 American Heart Association Scientific Sessions (2020) (5)
Coronary artery disease performance measures and statin use in patients with recent percutaneous coronary intervention or recent coronary artery bypass grafting (from the NCDR PINNACLE registry). (2015) (5)
Association of reproductive factors with dementia: A systematic review and dose-response meta-analyses of observational studies (2021) (5)
Shared decision making and patient reported outcomes among adults with atherosclerotic cardiovascular disease, medical expenditure panel survey 2006–2015 (2021) (4)
Can Sound Public Health Policies Stem the Tide of Burgeoning Epidemic of Cardiovascular Disease in South Asians? (2021) (4)
Noncardiac surgery following percutaneous coronary intervention (2004) (4)
Telomere length in young patients with acute myocardial infarction without conventional risk factors: A pilot study from a South Asian population (2020) (4)
Management of failed thrombolysis after acute myocardial infarction: an overview of current treatment options. (2007) (4)
Gaps in provider lifestyle counseling and its adherence among obese adults with prediabetes and diabetes in the United States. (2019) (4)
Burden and predictors of statin use in primary and secondary prevention of atherosclerotic vascular disease in the US: From the National Health and Nutrition Examination Survey 2017-2020. (2022) (4)
Association between remnant lipoprotein cholesterol, high-sensitivity C-reactive protein, and risk of atherosclerotic cardiovascular disease events in the Multi-Ethnic Study of Atherosclerosis (MESA). (2022) (4)
PCSK9 Inhibitors in the Management of Cardiovascular Risk: A Practical Guidance (2022) (4)
Plaque Volume of Carotid Endarterectomy Specimens Measured by 3D Ultrasound Technology. (2016) (4)
Leveraging structured and unstructured electronic health record data to detect reasons for suboptimal statin therapy use in patients with atherosclerotic cardiovascular disease (2021) (4)
Real-world data, theoretical application of guidelines, cost, and access: how do we optimize non-statin therapy for LDL-C/non-HDL-C/ApoB? (2020) (4)
High-Intensity Statins Benefit High-Risk Patients: Why and How to Do Better. (2021) (4)
Association Between Social Vulnerability Index and Cardiovascular Disease: A Behavioral Risk Factor Surveillance System Study (2022) (4)
Provider‐Level Variation in Smoking Cessation Assistance Provided in the Cardiology Clinics: Insights From the NCDR PINNACLE Registry (2019) (4)
Scope and Social Determinants of Food Insecurity Among Adults With Atherosclerotic Cardiovascular Disease in the United States (2021) (4)
ST Elevation: Telling Pathology from the Benign Patterns (2012) (4)
Comparison of surgical versus transcatheter aortic valve replacement for patients with aortic stenosis at low-intermediate risk. (2020) (4)
A way to track governments’ response and people’s mobility changes in response to COVID-19 pandemic (2020) (4)
Association of premature atherosclerotic cardiovascular disease with higher risk of cancer: a behavioral risk factor surveillance system study. (2021) (4)
Association of Coronary Artery Calcium Density and Volume with Predicted Atherosclerotic Cardiovascular Disease Risk and Cardiometabolic Risk Factors in South Asians: The Mediators of Atherosclerosis in South Asians Living in America (MASALA) Study. (2022) (4)
Evaluation of Factors Underlying Sex-Based Disparities in Cardiovascular Care in Adults With Self-reported Premature Atherosclerotic Cardiovascular Disease. (2022) (4)
Guideline-Concordant Statin Therapy Use in Secondary Prevention: Should the Medical Community Wait for Divine Intervention? (2022) (4)
Cardiovascular Disease Risk–Based Statin Utilization and Associated Outcomes in a Primary Prevention Cohort: Insights From a Large Health Care Network (2021) (4)
Therapy and clinical trials: HDL-cholesterol and niacin therapy--past, present, and future. (2010) (4)
2022 ACC Expert Consensus Decision Pathway for Integrating Atherosclerotic Cardiovascular Disease and Multimorbidity Treatment: A Framework for Pragmatic, Patient-Centered Care: A Report of the American College of Cardiology Solution Set Oversight Committee. (2022) (4)
Facility-Level Variation in Stress Test Utilization in Veterans With Ischemic Heart Disease. (2019) (4)
Association between poverty and appropriate statin prescription for the treatment of hyperlipidemia in the United States: An analysis from the ACC NCDR PINNACLE registry. (2019) (4)
Temporal Trends in Characteristics and Outcomes Associated With In‐Hospital Cardiac Arrest: A 20‐Year Analysis (1999–2018) (2021) (4)
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2022 American College of Cardiology Scientific Sessions (2022) (3)
Significant Facility-Level Variation in Utilization of and Adherence with Secondary Prevention Therapies Among Patients with Premature Atherosclerotic Cardiovascular Disease: Insights from the VITAL (Veterans wIth premaTure AtheroscLerosis) Registry7 (2021) (3)
The Effectiveness of a Worksite Lifestyle Intervention Program on High-Risk Individuals as Potential Candidates for Bariatric Surgery: My Unlimited Potential (MyUP). (2016) (3)
Prevalence and Determinants of Difficulty in Accessing Medical Care in U.S. Adults. (2021) (3)
Prescribing Patterns of Antihypertensive Medications in Low- and Middle-Income Countries: A Systematic Review (2020) (3)
nCorrelates of SGLT-2-inhibitiors Use Among Patients with Atherosclerotic Cardiovascular Disease and Type 2 Diabetes Mellitus: Insights from the Department of Veterans Affairs. (2021) (3)
Electronic health records and outpatient cardiovascular disease care delivery: Insights from the American College of Cardiology’s PINNACLE India Quality Improvement Program (PIQIP) (2018) (3)
National Trends and Disparities in Statin Use for Ischemic Heart Disease from 2006 to 2018: Insights from National Ambulatory Medical Care Survey. (2022) (3)
Social vulnerability and COVID-19: An analysis of CDC data (2021) (3)
From Plaque Burden to Plaque Composition: Toward Personalized Risk Assessment. (2017) (3)
The Role of Ezetimibe in the Treatment of Cardiovascular Disease (2016) (3)
The risk and severity of stroke in patients with atrial fibrillation and gout: A National Representative Database study (2021) (3)
Contrast echocardiography for right-sided heart conditions: case reports and literature review. (2008) (3)
Aspirin reduces cardiovascular events in primary prevention of cardiovascular disease but at a near equivalent risk of increased bleeding (2016) (3)
Safety and Efficacy of Colchicine in Patients with Stable CAD and ACS: A Systematic Review and Meta-analysis (2021) (3)
Epidemiology and risk factors for stroke in young individuals: implications for prevention (2021) (3)
Acute coronary syndromes: unstable angina and non-ST elevation myocardial infarction. (2014) (3)
Abstract 14835: Carotid Artery Plaque Burden and Characteristics and Subsequent Risk of Incident Cardiovascular Events: The Atherosclerosis Risk in Communities (ARIC) Carotid Magnetic Resonance Imaging Study (2013) (3)
SGLT-2 Inhibitors for Patients with Heart Failure: What Have We Learned Recently? (2022) (3)
Case report: isolated cardiac amyloidosis: an enigma unravelled. (2015) (3)
Association Between Cinnamon Consumption and Risk of Cardiovascular Health: A Systematic Review and Meta-Analysis. (2021) (3)
Understanding by General Providers of the Echocardiogram Report. (2019) (3)
Cholesterol Guidelines: More Similar Than Different. (2016) (3)
Egg Consumption and Risk of Cardiovascular Disease: a Critical Review (2021) (3)
Predictors of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibitor Prescriptions for Secondary Prevention of Clinical Atherosclerotic Cardiovascular Disease (2021) (3)
Harder-to-Treat Patients: Recognizing Them and Adapting Treatment Strategies. (2016) (3)
Understanding Self-regulation Behaviors in South Asians With Coronary Artery Disease: A Mixed-Methods Study (2017) (3)
Association of cardiovascular risk factor profile and financial hardship from medical bills among non-elderly adults in the United States (2020) (3)
Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD) guidelines for management of dyslipidemia and cardiovascular disease risk reduction: Putting evidence in context. (2021) (3)
Inflammatory bowel disease and atherosclerotic cardiovascular disease in U.S. adults—A population-level analysis in the national health interview survey (2022) (3)
Impact of COVID-19 on Outcomes of Patients Hospitalized With STEMI: A Nationwide Propensity-matched Analysis (2022) (2)
Cardiovascular disease risk by assigned treatment using the 2013 and 1998 obesity guidelines (2016) (2)
Association of participation in Cardiac Rehabilitation with Social Vulnerability Index: The behavioral risk factor surveillance system. (2022) (2)
Facility-Level Variation in Cardiac Stress Test Use Among Patients With Diabetes: Findings From the Veterans Affairs National Database (2020) (2)
Long-Term Effectiveness of the TIME Intervention to Improve Diabetes Outcomes in Low-Income Settings: a 2-Year Follow-Up (2022) (2)
Individual sentiments on telehealth in the COVID-19 era: Insights from Twitter (2022) (2)
Trends in Characteristics and Outcomes in Primary Heart Failure Hospitalizations Among Older Population in the United States, 2004 to 2018 (2022) (2)
Antihypertensive adherence and outcomes among community‐dwelling Medicare beneficiaries: the Atherosclerosis Risk in Communities Study (2018) (2)
Use of Oral Anticoagulants in Patients with Valvular Atrial Fibrillation: Findings From the NCDR PINNACLE Registry®. (2021) (2)
The potential of m-Health-based interventions to improve medication literacy and adherence in non-communicable diseases in Pakistan (2019) (2)
The Way to a Woman's Heart: Assessing, Personalizing, and Reclassifying Atherosclerotic Cardiovascular Disease Risk in Female Patients. (2020) (2)
Association of Elevated Triglycerides and Atherogenic Lipoproteins with Incident Cardiovascular Diseases: Insights from Genetic Data in the Atherosclerosis Risk in Communities Study (2017) (2)
Acute Tubular Injury in a Patient on a Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor (2020) (2)
SINGLE NUCLEOTIDE POLYMORPHISMS IN CHROMOSOME 4Q25 PREDICT IN-HOSPITAL AND LONG TERM DEVELOPMENT OF ATRIAL FIBRILLATION AND SURVIVAL IN PATIENTS UNDERGOING CORONARY ARTERY BYPASS GRAFTING (2011) (2)
The impact of multiple single day blood pressure readings on cardiovascular risk estimation: The Atherosclerosis Risk in Communities study (2016) (2)
Implications of the LEGACY trial on US Atrial Fibrillation Patients: An NCDR Research to Practice (R2P) Project. (2017) (2)
Association of polygenic risk scores with incident atherosclerotic cardiovascular disease events among individuals with coronary artery calcium score of zero: The multi-ethnic study of atherosclerosis. (2022) (2)
Implementation strategies to improve non-HDL-cholesterol goal attainment: current evidence and a conceptual framework for future directions. (2012) (2)
Abstract 10315: Cost-Effectiveness of Bempedoic Acid in Patients with Established Atherosclerotic Cardiovascular Disease (2021) (2)
Troponin T Measured by a Highly Sensitive Assay Predicts Coronary Heart Disease , Heart Failure , and Mortality in the Atherosclerosis Risk in Communities Study (2011) (2)
Temporal Trends in the Prevalence of Current E-Cigarette and Cigarette Use by Annual Household Income from 2016 to 2018 (From the Behavioral Risk Factor Surveillance System [BRFSS] Survey). (2020) (2)
COVID-19 and preventive strategy. (2022) (2)
Contemporary data on cardiovascular diseases in Indians: American College of Cardiology's PINNACLE India Quality Improvement Program. (2016) (2)
World Heart Federation Cholesterol Roadmap 2022 (2022) (2)
Efficacy and tolerability of multidrug therapy for hypertriglyceridemia. (2009) (2)
Rural-Urban Trends in Congenital Heart Disease-Related Mortality in the United States, 1999 to 2019 (2022) (2)
A Mistake Not to Be Repeated: What Can We Learn from the Underutilization of Statin Therapy for Efficient Dissemination of Cardioprotective Glucose Lowering Agents? (2022) (2)
Abstract 11: Compliance With Risk Factor Optimization and Medical Therapy in Patients With Peripheral Vascular Disease (Peripheral Artery and Ischemic Cerebrovascular Disease) Compared to Ischemic Heart Disease. (2015) (2)
Mentored implementation to initiate a diabetes program in an underserved community: a pilot study (2021) (2)
Midlife determinants of healthy cardiovascular aging: The Atherosclerosis Risk in Communities (ARIC) study. (2022) (2)
Association of patient, provider and facility related characteristics with statin associated side effects and statin use: Insight from the veteran's affairs healthcare system. (2021) (2)
Lipid Monitoring After Initiation of Lipid-Lowering Therapies: Return of Performance Measures? (2021) (2)
Abstract 189: Income Level Disparities in Consumer Reported Domains of Healthcare Experience Among Those With Established Atherosclerotic Cardiovascular Disease in United States: Insights From Medical Expenditure Panel Survey 2010-2013 (2017) (2)
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2022 European Society of Cardiology Congress (2022) (2)
ASSOCIATION OF INSURANCE TYPE WITH RECEIPT OF ORAL ANTICOAGULATION IN ATRIAL FIBRILLATION: AN ANALYSIS OF THE AMERICAN COLLEGE OF CARDIOLOGY NCDR PINNACLE REGISTRY (2016) (2)
Association of Smokeless Tobacco use with the use of other Illicit Drugs in the United States. (2020) (2)
Update on therapies targeting HDL: the mystery continues. (2011) (2)
Alcohol Consumption and Cardiovascular Health. (2022) (2)
Percutaneous coronary intervention before noncardiac surgery: more threat than benefit? (2004) (2)
Adherence to lipid monitoring and its impact on treat intensification of LDL-C lowering therapies at an urban academic medical center. (2022) (2)
AHA LIFE’S SIMPLE 7 METRICS ARE NOT SIGNIFICANTLY ASSOCIATED WITH SUBCLINICAL CORONARY ATHEROSCLEROSIS INCIDENCE OR PROGRESSION AMONG SOUTH ASIANS OR OTHER RACIAL/ETHNIC GROUPS: FINDINGS FROM THE MASALA AND MESA STUDIES (2022) (2)
Associations between Particulate Matter Air Pollution, Presence and Progression of Subclinical Coronary and Carotid Atherosclerosis: A Systematic Review (2020) (2)
LIPOPROTEIN(A) AND CORONARY ARTERY CALCIUM SCORE FOR PREDICTING ATHEROSCLEROTIC CARDIOVASCULAR DISEASE RISK (2020) (2)
IMPACT OF BIOMARKERS ON SHORT-TERM RISK PREDICTION OF GLOBAL CARDIOVASCULAR EVENTS IN OLDER ADULTS: ATHEROSCLEROSIS RISK IN COMMUNITIES STUDY (2018) (2)
The Utility of Coronary Artery Calcium for Guiding Treatment With Preventive Pharmacotherapy: Opportunities and Nuances. (2022) (2)
Meta-analysis of Per-Day Step Count and All-Cause Mortality. (2022) (2)
A simplified approach to identification of risk status in patients with atherosclerotic cardiovascular disease (2021) (2)
Comparing eligibility for statin therapy for primary prevention under 2022 USPSTF recommendations and the 2018 AHA/ACC/ multi-society guideline recommendations: From National Health and Nutrition Examination Survey. (2022) (2)
Revisiting diuretic choice in chronic kidney disease (2022) (2)
Lipid lowering therapy in 2022 and beyond - How far we have come. (2022) (2)
Association between hearing aid use and all-cause and cause-specific dementia: an analysis of the UK Biobank cohort. (2023) (1)
Patient perceptions and use of non‐statin lipid lowering therapy among patients with or at risk for atherosclerotic cardiovascular disease: Insights from the PALM registry (2021) (1)
PATIENTS’ PERCEIVED VERSUS PREDICTED CARDIOVASCULAR DISEASE RISK: CHALLENGES FOR SHARED DECISION-MAKING IN CHOLESTEROL MANAGEMENT (2016) (1)
Stroke‐Related Mortality in the United States–Mexico Border Area of the United States, 1999 to 2018 (2021) (1)
Abstract 166: Small Dense LDL Cholesterol Is Associated with Risk for Coronary Heart Disease: The Atherosclerosis Risk in Communities (ARIC) Study (2012) (1)
Mental Health and Access to Medical Care in Patients with Chronic Cardiovascular Conditions: An Analysis of the Behavior Risk Factor Surveillance System (2022) (1)
Aspirin With or Without Statin in Individuals Without Atherosclerotic Cardiovascular Disease Across Risk Categories (2023) (1)
Associations Between Carotid Artery Plaque Burden, Plaque Characteristics, and Cardiovascular Events: The ARIC Carotid Magnetic Resonance Imaging Study (2021) (1)
Same evidence, varying viewpoints: Three questions illustrating important differences between United States and European cholesterol guideline recommendations (2020) (1)
Sugar Sweetened and Artificially Sweetened Beverages Consumption and Risk of Cardiovascular Health. (2022) (1)
Clinical characteristics and mortality after acute myocardial infarction-related hospitalization among Asians from a national population-based cohort study. (2021) (1)
Is diabetes mellitus equivalent to atherosclerotic cardiovascular disease from a healthcare cost perspective? Insights from the Medical Expenditure Panel Survey: 2010–2013 (2018) (1)
Lipid management: Considerations in acute coronary syndrome (2008) (1)
IS HIGH-DOSE STATIN THERAPY ASSOCIATED WITH LOWER STATIN ADHERENCE COMPARED WITH LOW-DOSE STATIN THERAPY? AN ANALYSIS FROM A NATIONAL COHORT (2014) (1)
Unfavorable social determinants of health are associated with higher burden of financial toxicity among patients with atherosclerotic cardiovascular disease in the US: findings from the National Health Interview Survey (2022) (1)
Family income and cardiovascular disease risk in American adults (2023) (1)
Clinical and Economic Burden of Percutaneous Coronary Intervention in Hospitalized Young Adults in the United States, 2004-2018 (2021) (1)
Social Determinants of Health Among Non-Elderly Adults With Stroke in the United States. (2022) (1)
Sociodemographic determinants of oral anticoagulant prescription in patients with atrial fibrillations: findings from the PINNACLE registry using machine learning (2022) (1)
Abstract 19292: Cardiovascular Secondary Prevention Therapies are Underprescribed in Patients With Peripheral Artery Disease: Findings From the NCDR PINNACLE Registry (2017) (1)
Monoclonal Antibodies, Gene Silencing and Gene Editing (CRISPR) Therapies for the Treatment of Hyperlipidemia—The Future Is Here (2023) (1)
Predictors, Disparities, and Facility-Level Variation: SGLT2 Inhibitor Prescription Among US Veterans With CKD. (2023) (1)
Abstract 13002: Sociodemographic Disparities in Awareness of Heart Attack Symptoms in the United States (2019) (1)
PATIENT-PROVIDER RACIAL CONCORDANCE AND PATIENT REPORTED HEALTHCARE EXPERIENCE, AMONG ADULTS WITH ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: INSIGHTS FROM MEDICAL EXPENDITURE PANEL SURVEY, 2010-2013 (2018) (1)
Abstract 14405: Plaque Volume of Carotid Endarterectomy (CEA) Specimens Measured Using a Novel 3-Dimensional Ultrasound (3DUS) Technology (2011) (1)
Abstract 146: Drivers of Healthcare Costs Among Adults With Obesity in United States: 2012 Medical Expenditure Panel Survey (2016) (1)
Pragmatic Clinical Trials-Ready for Prime Time? (2021) (1)
TROPONIN T IDENTIFIES INDIVIDUALS AT HIGHER RISK FOR HEART FAILURE AMONG ALL BLOOD PRESSURE CATEGORIES IN THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY (2014) (1)
State-Level Social Vulnerability Index and Healthcare Access: The Behavioral Risk Factor Surveillance System Survey. (2022) (1)
Racial and Geographic Disparities in Internet Use in the U.S. Among Patients With Hypertension or Diabetes: Implications for Telehealth in the Era of Coronavirus Disease 2019 (2020) (1)
Metrics of Quality Care in Veterans: Correlation Between Primary‐Care Performance Measures and Inappropriate Myocardial Perfusion Imaging (2015) (1)
Abstract 16752: Cumulative Social Determinant of Health Risk Score and Prevalent Atherosclerotic CVD Among National Representative Adult Population in US (2020) (1)
Use of preventive cardiovascular health care among Asian American individuals: A National Health Interview Survey Study. (2022) (1)
Abstract P162: Has LDL Cholesterol (LDL-C) and Non-HDL Cholesterol (Non-HDL-C) Goal Attainment Improved 7 Years After Adult Treatment Panel III (ATP III) Guidelines Were Published? (2011) (1)
Abstract 002: Patient Provider Communication and Patient-centered Outcomes Among Patients With Atherosclerotic Cardiovascular Disease in United States: Medical Expenditure Panel Survey 2010-2013 (2017) (1)
Hypertension in Women: A South-Asian Perspective (2022) (1)
Barriers to Prompting Beta Blocker Titration in Heart Failure at the Point of Care (2017) (1)
Association of Body Mass Index With Risk Factor Optimization and Guideline-Directed Medical Therapy in US Veterans With Cardiovascular Disease (2019) (1)
Association of dementia with in-hospital outcomes in primary heart failure and acute myocardial infarction hospitalizations. (2022) (1)
Temporal Trends in Lipoprotein(a) Concentrations: The Atherosclerosis Risk in Communities Study (2022) (1)
ASSOCIATION OF REMNANT-LIKE PARTICLE CHOLESTEROL AND LOW-DENSITY LIPOPROTEIN TRIGLYCERIDE WITH INCIDENCE OF CARDIOVASCULAR EVENTS: THE ARIC STUDY (2017) (1)
Abstract 12446: Frequency and Practice Level Variation in Statin Use Among Patients With Diabetes: Insights From the NCDR® PINNACLE Registry (2015) (1)
Abstract 138: Contemporary Patterns of Use of Antiplatelet Agents in Patients With Acute Myocardial Infarction: Insight From the National Cardiovascular Data Registry (NCDR) (2016) (1)
THE PROGNOSTIC ROLE OF MATRIX METALLOPROTEINASE 7 (MMP-7) AMONG OLDER ADULTS: ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY (2021) (1)
Demographic and Regional Trends of Hypertrophic Cardiomyopathy-Related Mortality in the United States, 1999 to 2019 (2022) (1)
The Effect of Yoga on Cardiovascular Disease Risk Factors: A Meta-Analysis. (2023) (1)
Impact of COVID-19 in patients hospitalized with stress cardiomyopathy: A nationwide analysis (2022) (1)
Abstract 25: Favorable Modifiable Cardiovascular Risk Profile is Associated with Lower Healthcare Costs: The 2012 Medical Expenditure Panel Survey (2016) (1)
Abstract P087: Ethnic and Educational Disparities in Morbid Obesity Among Employees of a Large Healthcare Organization: The Baptist Health South Florida Employee Study (2016) (1)
Correlates of Glucagon-Like Peptide-1 Receptor Agonist Use Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes Mellitus (from the Department of Veterans Affairs). (2022) (1)
IMPACT OF GENDER ON MORTALITY AND MORBIDITY AFTER ISOLATED CORONARY ARTERY BYPASS GRAFTING: A PROPENSITY MATCHED ANALYSIS OF OUTCOMES (2011) (1)
Secondary prevention of cardiovascular diseases in India: Findings from registries and large cohorts (2020) (1)
Abstract 19671: Percutaneous Coronary Interventions with Drug-Eluting Stents for Unprotected Left Main Coronary Artery Stenosis are Associated with Reduced Stroke and Increased Repeat Revascularization Risk Compared with Coronary Artery Bypass Graft Surgery: Results from a Contemporary Aggregate Dat (2010) (1)
Case report: a lead you can't miss: a case of right ventricular perforation. (2015) (1)
REMARKABLE EFFICACY OF BEMPEDOIC ACID IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (HEFH) (2021) (1)
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2022 American Heart Association Scientific Sessions (2023) (1)
Reducing Cardiovascular Risk in the Medicare Million Hearts Risk Reduction Model: Insights From the National Cardiovascular Data Registry PINNACLE Registry (2018) (1)
Statins in COVID-19 infection: A rehash of old themes or truly a new hope? (2021) (1)
Association of Long-term Change in N-Terminal Pro-B-Type Natriuretic Peptide With Incident Heart Failure and Death. (2023) (1)
Association of Body Mass Index with Outcomes in Patients Undergoing Percutaneous Left Atrial Appendage Closure with the Watchman Device. (2021) (1)
COMPARISON OF PERCUTANEOUS CORONARY INTERVENTION VERSUS CORONARY ARTERY BYPASS GRAFTING IN OLDER ADULTS WITH UNPROTECTED LEFT MAIN CORONARY ARTERY DISEASE: A META-ANALYSIS AND METAREGRESSION (2019) (1)
SHORT AND LONG TERM OUTCOMES OF PERCUTANEOUS CORONARY INTERVENTION VERSUS CORONARY ARTERY BYPASS GRAFTING IN OLDER (>70 YEARS) PATIENTS WITH UNPROTECTED LEFT MAIN CORONARY ARTERY DISEASE IN THE ERA OF DRUG ELUTING STENTS (2016) (1)
Impact of Social Vulnerability on Comorbid Cancer and Cardiovascular Disease Mortality in the United States (2022) (1)
USE AND ADHERENCE WITH STATINS AND ASPIRIN THERAPY AMONG PATIENTS WITH PREMATURE ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: AN ANALYSIS FROM THE VITAL (VETERANS WITH PREMATURE ATHEROSCLEROSIS) REGISTRY (2020) (1)
Abstract 25: Patient-reported Outcomes, Resource Utilization, and Healthcare Expenditures Across the 3 Major Atherosclerotic Diseases: The Medical Expenditure Panel Survey (meps) (2020) (1)
ASSOCIATION OF PLASMA DEHYDROEPIANDROSTERONE SULFATE (DHEA-S) WITH INCIDENT HEART FAILURE IN OLDER MEN AND WOMEN (2020) (1)
Contemporary outcomes studies to identify and mitigate the risk in patients with premature cardiovascular disease (2021) (1)
Percutaneous coronary intervention in patients with cardiac allograft vasculopathy: a Nationwide Inpatient Sample (NIS) database analysis (2021) (1)
Reclassification of Pre-Heart Failure Stages Using Cardiac Biomarkers: Atherosclerosis Risk in Communities (ARIC) Study. (2023) (1)
Comparative Outcomes of Percutaneous Coronary Intervention for ST-Segment–Elevation Myocardial Infarction Among Medicare Beneficiaries With Multivessel Coronary Artery Disease (2021) (1)
Strength training and cardiovascular health: A meta-analysis. (2022) (1)
Aberrant Course of Pacemaker Leads: When Left is Left. (2018) (1)
Abstract 15347: Provider Type and Quality of Outpatient Cardiovascular Disease Care, Implications for the Affordable Care Act: Insights from the NCDR®PINNACLE Registry (2014) (1)
BEHAVIORAL RISK FACTORS AND PREMATURE ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: AN ANALYSIS FROM THE VITAL (VETERANS WITH PREMATURE ATHEROSCLEROSIS) REGISTRY (2020) (1)
Gender Differences in Clinical Outcomes After Percutaneous Coronary Intervention-Analysis of 15,106 Patients from the Cardiac Registry of Pakistan Database. (2023) (1)
PM2.5 and Cardiovascular Health Risks. (2023) (1)
Lipid-Lowering Therapies: Risks in Women and Evidence-Based Options. (2018) (1)
Methodological Rigor and Temporal Trends of Cardiovascular Medicine Meta‐Analyses in Highest‐Impact Journals (2021) (1)
PRACTICE-LEVEL VARIATION IN STATIN USE AND LDL-C CONTROL IN THE UNITED STATES: RESULTS FROM THE PATIENT AND PROVIDER ASSESSMENT OF LIPID MANAGEMENT (PALM) REGISTRY (2019) (1)
Genetic Testing for Hypertriglyceridemia in Academic Lipid Clinics: Implications for Precision Medicine—Brief Report (2022) (1)
Substance Use and Premature Atherosclerotic Cardiovascular Disease (From the CDC Behavioral Risk Factor Surveillance System [BRFSS] Survey) (2021) (1)
Abstract 19538: Racial Disparities in the Utilization of Cardiovascular Disease Preventive Care Services in the United States: Insight From Medical Expenditure Panel Survey 2014 (2017) (1)
Cardiac sarcoidosis: a clinical entity uncommonly recognized. (2009) (1)
State-Level Social Vulnerability Index and Healthcare Access in Patients With Atherosclerotic Cardiovascular Disease (from the BRFSS Survey). (2022) (1)
Abstract 18494: Highly Sensitive Cardiac Troponin T is Associated with Incident Major Cardiovascular Events and Death: the Atherosclerosis Risk in Communities (ARIC) Study (2010) (1)
Abstract 19135: Small, Dense LDL Has Protective Association for Long-Term Mortality After Myocardial Infarction Compared With Large, Buoyant LDL Particles: Insights From the TRIUMPH Study (2016) (1)
Carotid arterial wall characteristics are associated with incident ischemic stroke but not coronary heart disease in the ARIC Study (2011) (1)
Cigarette smokers' perceptions of smoking cessation and associated factors in Karachi, Pakistan. (2021) (1)
The 2013 ACC/AHA Cholesterol Management Guideline: Clearing the Confusion from Noncontroversial Components. (2016) (1)
Risk Assessment of Stroke in Patients with Atrial Fibrillation: Current Shortcomings and Future Directions (2019) (1)
SINGLE NUCLEOTIDE POLYMORPHISMS IN CHOLESTERYL ESTER TRANSFER PROTEIN (CETP) GENE ARE NOT ASSOCIATED WITH RECURRENT CARDIOVASCULAR EVENTS OR MORTALITY IN PATIENTS WITH ESTABLISHED ATHEROSCLEROSIS: A MENDELIAN RANDOMIZATION EXPERIMENT (2013) (1)
Postoperative Renal Insufficiency among Patients Undergoing Cardiac Surgery (2009) (1)
COMPARISON OF FRIEDEWALD AND BIOLOGIC LDL-C IN FAMILIAL HYPERCHOLESTEROLEMIA SCREENING: THE VERY LARGE DATABASE OF LIPIDS STUDY-17 (VLDL-17) (2014) (1)
TRENDS IN PREVALENCE OF E-CIGARETTE USE AMONG U.S. ADULTS. BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM, 2016 AND 2017 (2020) (1)
ARTERIAL WALL CHARACTERISTICS ARE ASSOCIATED WITH INCIDENT CARDIOVASCULAR DISEASE: AN ANALYSIS FROM THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY (2010) (1)
Abstract 19516: Trends in Non-Statins Utilization and Expenditures Among U.S. Adults With Established Atherosclerotic Cardiovascular Disease: Medical Expenditure Panel Survey 2002-2013 (2016) (0)
Abstract 11088: Trend, Predictors and Outcomes of Transcatheter Aortic Valve Implantation in Patients with Bicuspid Aortic Valve; A National Inpatient Sample Database Analysis (2021) (0)
Abstract 008: Statin Use and Its Facility Level Variation in Patients With Peripheral Artery Disease: Insights From the Department of Veterans Affairs (2017) (0)
Identification and Management of Atherosclerotic Cardiovascular Disease Risk in South Asian Populations in the U.S. (2023) (0)
Novel antithrombotic regimen in patients with ischemic heart disease and peripheral arterial disease: can we identify those who derive the highest benefit? (2020) (0)
ASSOCIATIONS BETWEEN A SINGLE NUCLEOTIDE POLYMORPHISM IN CHROMOSOME 9P21 AND ARTERIAL STIFFNESS IN THE ATHEROSCLEROSIS RISK IN COMMUNITIES STUDY (2011) (0)
Abstract 18084: Assessment of Echocardiogram Report Interpretation by General Providers (2017) (0)
Sa488 ULCERATIVE COLITIS PATIENTS HAVE HIGHER INCIDENCE OF MYOCARDIAL INFARCTION AS COMPARED TO CROHN'S DISEASE: DATA FROM A LARGE COHORT OF UNITED STATES VETERANS FROM 2002 TO 2015 (2021) (0)
Heterogeneity in the prevalence of premature hypertension among Asian American populations compared with white individuals: A National Health Interview Survey study (2022) (0)
Epidemiology and Prevention Associations Between Lipoprotein ( a ) Levels and Cardiovascular Outcomes in Black and White Subjects The Atherosclerosis Risk in Communities ( ARIC ) Study (2012) (0)
RISK PROFILE AND OUTCOMES OF PATIENTS WITH PREMATURE AND EXTREMELY PREMATURE CORONARY ARTERY DISEASE COMPARED WITH OLDER ADULTS: ANALYSIS OF THE CARDIAC REGISTRY OF PAKISTAN (CROP) DATABASE (2022) (0)
LABORATORY TRENDS IN INDIVIDUALS WITH PREMATURE CAD FROM THE NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY DATABASE (2022) (0)
HDL-cholesterol and causes of death in chronic kidney disease (2018) (0)
Potential Impact of 2017 American College of Cardiology/American Heart Association Hypertension Guideline on Contemporary Practice: A Cross‐Sectional Analysis From NCDR PINNACLE Registry (2022) (0)
Abstract 453: Ceruloplasmin and Cardiovascular Disease in the Atherosclerosis Risk in Communities (ARIC) Study (2012) (0)
Abstract 12264: Coronary Artery Calcium Stratifies Risk Across Varying Levels of Dyslipidemia: The Multi-Ethnic Study of Atherosclerosis (MESA) (2012) (0)
Abstract 18496: Trends in Healthcare Expenditures and Cardiovascular Risk Profile Among Individuals Without ASCVD: Analysis of the Medical Expenditure Panel Survey 2002-2013 (2016) (0)
Abstract 11929: Lipoprotein(a) and Family History of Coronary Heart Disease Are Additive for Predicting Long-Term Cardiovascular Risk: The Atherosclerosis Risk in Communities (ARIC) Study (2018) (0)
PREVALENCE AND MANAGEMENT OF PATIENT-REPORTED SYMPTOMS ON STATIN THERAPY: INSIGHTS FROM THE PATIENT AND PROVIDER ASSESSMENT OF LIPID MANAGEMENT (PALM) REGISTRY (2016) (0)
CHA2DS2-VASc-HSF score – New predictor of severity of coronary artery disease in 2172 patients (2015) (0)
IMPLICATIONS OF THE FDA APPROVAL OF PCSK9 INHIBITORS FOR CONTEMPORARY CARDIOVASCULAR PRACTICE: FINDINGS FROM THE NCDR® RESEARCH TO PRACTICE (R2P) PROJECT (2017) (0)
Analysis of Knowledge and Barriers to Non-High-Density Lipoprotein Cholesterol Goal Attainment Among Physicians in Training* (2011) (0)
Health care costs associated with primary care physicians versus nurse practitioners and physician assistants (2021) (0)
Abstract 20263: Does the Gender of the Healthcare Provider Influence Health Outcomes Among Patients With Atherosclerotic Cardiovascular Disease in the United States: Insight From Medical Expenditure Panel Survey (meps) 2010-2013 (2017) (0)
TCT-835 Comparison of Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting for Unprotected Left Main Coronary Artery Disease in Patients with Diabetes: A Meta-Analysis (2017) (0)
Epidemiology and Prevention Cardiac Troponin T Measured by a Highly Sensitive Assay Predicts Coronary Heart Disease, Heart Failure, and Mortality in the Atherosclerosis Risk in Communities Study (2011) (0)
THE ASSOCIATION OF GROWTH DIFFERENTIATION FACTOR-15 AND RISK OF SHORT-TERM INCIDENT ATHEROSCLEROTIC CARDIOVASCULAR DISEASE, HEART FAILURE HOSPITALIZATION, AND ALL-CAUSE MORTALITY IN OLDER ADULTS: THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY (2020) (0)
Abstract P559: National Burden & Cardiovascular Risk Factor Profile of Stroke Among Young Adults in The United States (2020) (0)
Do Biomarkers Improve Short-term Risk Prediction of Global Cardiovascular Events in Older Adults? Insights from the Atherosclerosis Risk in Communities Study* (2018) (0)
Abstract P122: The Clinical Impact of TC/HDL-C Discordance With LDL-C and Non-HDL-C: 20 Year Follow-up of the Atherosclerosis Risk in Communities (ARIC) Study (2017) (0)
2019 American College of Cardiology (ACC)/American Heart Association (AHA) guidelines on the primary prevention of cardiovascular diseases (2019) (0)
Racial Disparities in Clinical Outcomes and Resource Utilization of Type 2 Myocardial Infarction in the United States: Insights from the National Inpatient Sample Database. (2022) (0)
Abstract 311: Comparative Effectiveness of Outpatient Cardiovascular Disease Care Delivery Between Physician and Non-Physician Primary Care Providers: Implications for Care Under the Affordable Care Act (2015) (0)
STATIN THERAPY IN PATIENTS WITH CEREBROVASCULAR DISEASE VERSUS CORONARY ARTERY DISEASE: INSIGHTS FROM THE PALM REGISTRY (2019) (0)
Age-Related Disparity Trends in Stroke-Related Mortality in the United States, 1999 to 2019. (2022) (0)
Abstract 10588: Medicare Part D Medication Use in a Community Cohort With Hypertension: The Atherosclerosis Risk in Communities (ARIC) Study (2013) (0)
Glucocentric Drugs in Cardiovascular Disease Protection and Heart Failure (2022) (0)
Abstract 213: Interplay of Health-Related Quality of Life, Cardiovascular Disease and Healthcare Costs: 2012 Medical Expenditure Panel Survey (2016) (0)
Abstract 303: Pre-operative Angiotensin Converting Enzyme Inhibitor use and outcomes in patients undergoing Isolated Coronary Artery Bypass Grafting (2012) (0)
Outcomes in culprit only versus multivessel percutaneous coronary intervention in ST elevation myocardial infarction during index procedure (2016) (0)
Developing a Parsimonious Frailty Index for Older, Multimorbid Adults With Heart Failure Using Machine Learning. (2022) (0)
Abstract 15670: Age-related Differences in the Contribution of Systolic Blood Pressure and Biomarkers to Cardiovascular Disease Risk Prediction: The Atherosclerosis Risk in Communities (ARIC) Study (2020) (0)
Abstract 17240: Differences in Longitudinal Trends in Skeletal Thigh Muscle Area Assessed With Magnetic Resonance Imaging Among Diabetic and Non-Diabetic Peripheral Artery Disease Patients (2017) (0)
ASPIRIN DOSING IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION TREATED WITH TICAGRELOR: INSIGHT FROM THE NATIONAL CARDIOVASCULAR DATA REGISTRY (NCDR) (2016) (0)
ASSOCIATION BETWEEN TRADITIONAL CHOLESTEROL PARAMETERS, LIPOPROTEIN PARTICLE CONCENTRATION, NOVEL BIOMARKERS AND CAROTID PLAQUES IN RETIRED NATIONAL FOOTBALL LEAGUE PLAYERS (2011) (0)
MRI VENOUS VOLUME MEASUREMENTS IN PERIPHERAL ARTERIAL DISEASE: A PILOT STUDY FROM THE EFFECT OF LIPID MODIFICATION ON PERIPHERAL ARTERIAL DISEASE AFTER ENDOVASCULAR INTERVENTION (ELIMIT) STUDY (2011) (0)
CLINICAL CHARACTERISTICS OF PATIENTS CLASSIFIED AS VERY HIGH RISK AND NOT VERY HIGH RISK BASED ON THE 2018 AHA/ACC MULTI-SOCIETY CHOLESTEROL GUIDELINE (2020) (0)
Use of cardiopulmonary pump support during coronary artery bypass grafting in the high-risk: a meta-analysis (2018) (0)
ASSOCIATION BETWEEN CARDIOLOGY VISIT AND EVIDENCE-BASED STATIN PRESCRIPTION AND STATIN ADHERENCE PATTERNS: FINDINGS FROM THE VETERANS AFFAIRS NATIONAL DATABASE (2019) (0)
Guideline recommended medication use among systolic heart failure patients in India: Insights from the American college of cardiology practice innovation and clinical excellence (PINNACLE)® India Registry (2014) (0)
FACTORS ASSOCIATED WITH USE OF NEWER ANTIPLATELET AGENTS IN PATIENTS UNDERGOING DRUG ELUTING STENT PLACEMENT: ANALYSIS FROM THE PINNACLE® REGISTRY (2015) (0)
Do all chronically ill persons benefit equally from Medicare (2012) (0)
Abstract 18978: Associations of Provider Knowledge and Beliefs Regarding Lipid Management With Statin Therapy Use and Lipid Outcomes (2017) (0)
Apolipoprotein A 1 and Standard Lipid Measures in the Prediction of Incident Coronary Heart Disease : The Atherosclerosis Risk in Communities ( ARIC ) Study b . Abbreviated Title ( Length 26 characters ) : Apolipoproteins and CHD risk 2 (2010) (0)
Abstract 254: Persistent SES Disparities in Cardiovascular Risk Factors and Health in the United States: MEPS 2002-2013 (2017) (0)
Patterns Of Care, Costs And Outcomes Of Chest Pain Patients Within Two Years Of Initial Visits To The ER (2013) (0)
Association Between Low Density Lipoprotein Cholesterol or Low Density Lipoprotein Particle Concentration and Metabolic Syndrome and High Sensitivity C-Reactive Protein in Retired National Football League Players* (2014) (0)
Should scope of practice laws for advanced practice providers be revised (2017) (0)
PREVALENCE AND DETERMINANTS OF DIFFICULTY ACCESSING MEDICAL CARE IN ADULTS WITH CHRONIC DISEASE RESULTS FROM THE BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM (BRFSS) SURVEY (2021) (0)
Abstract 19292: The Efficacy of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients with Coronary Artery Disease and No Heart Failure in the Modern Statin Era: a Meta-Analysis of Randomized-Controlled Trials (2014) (0)
Abbreviated Title ( Length 26 characters ) : Machine learning based HF risk prediction 2 (2018) (0)
IMPLICATIONS OF THE IMPROVE-IT TRIAL FOR CONTEMPORARY CARDIOVASCULAR PRACTICE: AN NCDR® RESEARCH TO PRACTICE (R2P) PROJECT (2017) (0)
Abstract 19771: Persistent Thrombocytopenia after Myocardial Infarction is Associated with Increased Short- and Long-Term Mortality (2014) (0)
Abstract 18418: Favorable Cardiovascular Risk Profile is Associated With Lower Out-of-Pocket Health Care Financial Burden: Medical Expenditure Panel Survey (2010-2013) (2016) (0)
Lipoprotein Associated Phospholipase A2 Mass is Not Associated with Subclinical Coronary and Carotid Atherosclerosis in the Retired National Football League Players (2014) (0)
ASSOCIATION OF NT-PROBNP, PULSE PRESSURE WITH HEART FAILURE AND CARDIOVASCULAR EVENTS: ATHEROSCLEROSIS RISK IN COMMUNNITIES (ARIC) STUDY (2020) (0)
1.a. Full Title: Relationship between Lipoprotein Cholesterol levels and Carotid artery plaque characteristics: the ARIC Carotid MRI (2008) (0)
The Promise of Proprotein Convertase Subtilisin/Kexin 9 Inhibitors for the Treatment of Familial Hypercholesterolemia (2015) (0)
S791 Coronary Artery Calcium Score for Assessment of Cardiovascular Risk in Patients With Inflammatory Bowel Disease (2021) (0)
Abstract 13762: SDF 1 Alpha and Carotid plaque Characteristics: the Atherosclerosis Risk in Communities (ARIC) Carotid MRI Study (2013) (0)
Transatlantic guidelines on dyslipidemia and cardiovascular risk: key differences across the pond. (2020) (0)
Trend, predictors, and outcomes of combined mitral valve replacement and coronary artery bypass graft in patients with concomitant mitral valve and coronary artery disease: a National Inpatient Sample database analysis (2022) (0)
SLEEP DURATION, MORTALITY AND STROKE AMONG ASIAN POPULATIONS: A META-ANALYSIS (2023) (0)
Abstract 230: Per Capita Proportion of Total Health Care Expenditures on Pharmaceuticals Among US Adults With Cardiovascular Disease: 2012 Medical Expenditure Panel Survey (2016) (0)
With Current Safety and Efficacy Data, Should Statins Be Made Available as Nonprescription Over-the-Counter Drugs? (2023) (0)
Abstract 16019: MRI Venous Volume Measurements are Associated With Ankle Brachial Index in Peripheral Artery Disease Patients: Results From the Effect of Lipid Modification on Peripheral Arterial Disease After Endovascular Intervention Trial (ELIMIT) (2014) (0)
Barriers to Non-HDL-Cholesterol Goal Attainment: Exploring the Gaps in Knowledge, Attitude, and Practices of Providers* (2011) (0)
Premorbid Body-Mass Index and Mortality after Incident Heart Failure: The Atherosclerosis Risk in Communities Study (2014) (0)
RACIAL DISPARITIES IN GUIDELINE DIRECTED STATIN IMPLEMENTATION AND CARDIOVASCULAR OUTCOMES: INSIGHTS FROM A REAL WORLD PRIMARY PREVENTION COHORT (2021) (0)
Abstract 18367: Association of Neighborhood Socioeconomic Status With Smoking Cessation Assistance Provided in the Cardiology Practices: Insights From the NCDR PINNACLE Registry (2017) (0)
LONG-TERM MORTALITY IN PATIENTS WITH SEVERE HYPERCHOLESTEROLEMIA PHENOTYPE FROM AN ETHNICALLY DIVERSE US COHORT (2023) (0)
Abstract 18250: Favorable Modifiable Cardiovascular Risk Profile is Associated With Lower Healthcare Costs Among Cancer Patients: The 2013 Medical Expenditure Survey (2016) (0)
Abstract 11933: The Impact of the Eighth Joint National Committee Guidelines for the Treatment of High Blood Pressure on an Older US Cohort: The Atherosclerosis Risk in Communities Study (2014) (0)
HISTORICAL NEIGHBORHOOD REDLINING CONTINUES TO ADVERSELY INFLUENCE CARDIOVASCULAR OUTCOMES IN US VETERANS WITH ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (2023) (0)
When Is It Appropriate to Publish a Meta-Analysis in Cardiovascular Drugs and Therapy? (2023) (0)
Continuity of care and outpatient management for patients with and at high risk for cardiovascular disease during the COVID-19 pandemic: A scienti ﬁ c statement from the American Society for Preventive Cardiology American Journal of Preventive Cardiology (2020) (0)
Association of NT-proBNP, Blood Pressure, and Cardiovascular Events: Atherosclerosis Risk in Communities Study (2021) (0)
106: Efficacy and Safety of Multi-drug Therapy for Hypertriglceridemia (2008) (0)
What is really new in triglyceride guidelines? (2023) (0)
ASSOCIATION BETWEEN 6-YEAR CHANGE IN NT-PROBNP WITH HEART FAILURE AND DEATH: THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY (2022) (0)
A17044 Community health workers for non-communicable disease interventions in the digital age (2018) (0)
ASSOCIATIONS BETWEEN LIPOPROTEIN CHOLESTEROL FRACTIONS AND MEASURES OF PLATELET AGGREGATION IN PATIENTS WITH PERIPHERAL ARTERIAL DISEASE (2010) (0)
Sex differences in the association between cardiovascular diseases and dementia subtypes: a prospective analysis of 464,616 UK Biobank participants (2022) (0)
Racial disparity in flu vaccine uptake among Asian American Individuals: A National Health Interview Survey Study. (2022) (0)
RHEUMATOLOGIC DISORDERS AND PREMATURE ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: AN ANALYSIS FROM THE VITAL (VETERANS WITH PREMATURE ATHEROSCLEROSIS) REGISTRY (2020) (0)
ELIGIBILITY AND COST OF LOW-DOSE RIVAROXABAN BASED ON COMPASS TRIAL: INSIGHTS FROM THE VETERANS AFFAIRS HEALTHCARE SYSTEM (2020) (0)
Supplementary material : Gender Disparities in Evidence-Based Statin Therapy in Patients With Cardiovascular Disease (2014) (0)
Abstract 15: Frequency and Predictors of Inappropriate Aspirin Prescribing for Primary Prevention of Cardiovascular Disease: Insights from the NCDR® PINNACLE Registry. (2014) (0)
Abstract 13937: Statin Eligibility, Coronary Artery Calcium, and Subsequent Cardiovascular Events According to the 2016 USPSTF Statin Guidelines: The Multi-Ethnic Study of Atherosclerosis (2017) (0)
Abstract 060: Association of Body Mass Index With Risk Factor Optimization and Guideline Directed Medical Therapy in Veterans With Cardiovascular Disease (2017) (0)
Low Density Lipoprotein Triglyceride and Incident Cardiovascular: Insights from the Atherosclerosis Risk in Communities Study* (2018) (0)
Number of Live Births, Age at the Time of Having a Child, Span of Births and Risk of Dementia: A Population-Based Cohort Study of 253,611 U.K. Women. (2023) (0)
Abstract P036: Association Between Circulating Galectin-3 and Arterial Stiffness in the Atherosclerosis Risk in Communities Study (2019) (0)
CONVERSION OF CARDIOVASCULAR RANDOMIZED CONTROL TRIALS PRESENTED AT MAJOR CONFERENCES TO PUBLICATIONS (2021) (0)
Lipoprotein (a) levels and Risk of Cardiovascular Disease Events in Diabetes Mellitus and Prediabetes: The Atherosclerosis Risk in Communities Study (2017) (0)
ACUTE KIDNEY INJURY: A RARE CONSEQUENCE OF PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 INHIBITOR USE (2020) (0)
Association of pessimism with cardiovascular events and all-cause mortality. (2022) (0)
Outcomes of Intravascular Imaging in Orbital Atherectomy; Insight From the National Readmissions Database. (2022) (0)
Temporal Changes in Cost-Related Medication Nonadherence by Race/Ethnicity and Medicaid Expansion: The Behavioral Risk Factor Surveillance System Survey. (2021) (0)
POLYGENIC RISK SCORES AND INCIDENT ATHEROSCLEROTIC CARDIOVASCULAR DISEASE AMONG INDIVIDUALS WITH A CAC SCORE OF ZERO: THE MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS: MESA (2022) (0)
Abstract 15219: Statin Decision-Making Since the 2013 AHA/ACC Cholesterol Guidelines: Do Clinicians Do What They Say? (2017) (0)
Abstract 19025: Management and Outcomes of Acute Coronary Syndromes in Developing Countries: A Systematic Review (2017) (0)
"Zero": The New Superhero or Superhero in Training? (2019) (0)
108: Is Obesity an Independent Predictor of Post-operative Renal Insufficiency? (2008) (0)
Cardiorespiratory Fitness and Incident Stroke Types: The FIT (Henry Ford ExercIse Testing) Project. (2020) (0)
Variation in Statin Prescription among Veterans with HIV and Known Atherosclerotic Cardiovascular Disease. (2022) (0)
Statin Use and Risk of Diabetes by Subclinical Atherosclerosis Burden (from a Multi-Ethnic Study of Atherosclerosis Report). (2022) (0)
Abstract 17279: Have the 2013 AHA/ACC Cholesterol Guidelines Affected Clinicians’ Lipid Management Strategies? (2015) (0)
Abstract 16126: Cumulative Impact of Social Determinants of Health Risk Score on Obesity Among Young Adults in the United States (2020) (0)
Chapter-55 Hyperlipidemia (2015) (0)
DETERMINANTS OF INCIDENT STROKE AMONG THOSE WITH ABSENT CORONARY ARTERY CALCIFICATION: RESULTS FROM THE MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (2023) (0)
SUGAR SWEETENED BEVERAGES CONSUMPTION AND RISK OF CARDIOVASCULAR HEALTH (2023) (0)
IMPACT OF ELECTRONIC HEALTH RECORDS ON THE QUALITY OF OUTPATIENT CARDIOVASCULAR CARE DELIVERY IN INDIA: INSIGHTS FROM THE AMERICAN COLLEGE OF CARDIOLOGY'S PINNACLE INDIA QUALITY IMPROVEMENT PROGRAM (PIQIP) (2017) (0)
Abstract 15625: Social Determinants of Health and Non-cigarette Tobacco Products:results From the 2014-2017 National Health Interview Survey (2020) (0)
Abstract 12931: Does Reporting Non-High-Density-Lipoprotein Cholesterol (Non-HDL-C) Levels on Standard Lipid Panel Improve Non-HDL-C Goal Attainment (2011) (0)
LIPID-LOWERING THERAPY INTENSIFICATION AMONG UNITED STATES VETERANS FOLLOWING MYOCARDIAL INFARCTION OR CORONARY REVASCULARIZATION BETWEEN 2015 AND 2019 (2022) (0)
Abstract 20205: Patients with Severe Chronic Kidney Disease have Survival Benefit from Initial Invasive Therapy and Early Revascularization after Acute Coronary Syndrome (2010) (0)
A MULTICENTER STUDY OF THE ETIOLOGY AND OUTCOME OF CARDIAC TAMPONADE IN THE CONTEMPORARY ERA (2016) (0)
Abstract 304: The Outcomes of Pre-Procedural Angiotensin Converting Enzyme Inhibitor Therapy in patients undergoing Percutaneous Coronary Intervention (2012) (0)
Heart Failure and Cardiomyopathies CLINICAL OUTCOMES OF β -BLOCKER THERAPY IN COCAINE-ASSOCIATED HEART FAILURE (2014) (0)
Association of U.S. birth, duration of residence in the U.S., and atherosclerotic cardiovascular disease risk factors among Asian adults (2022) (0)
Abstract 66: Small Dense LDL Cholesterol Predicts Incident Diabetes Mellitus: The Atherosclerosis Risk in Communities Study (2014) (0)
UTILIZATION RATES OF SGLT2 INHIBITORS AND THEIR FACILITY-LEVEL VARIATION AMONG PATIENTS WITH TYPE 2 DIABETES (T2DM), HEART FAILURE (HF) AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD): INSIGHTS FROM THE DEPARTMENT OF VETERANS AFFAIRS (VA) (2023) (0)
REVISITING ELECTRONIC FRAILTY INDEX BY ADDING A LAB-BASED MARKER OF NUTRITION: A HEART FAILURE COHORT (2022) (0)
Abstract 18529: Trends in Direct Healthcare Expenditures Among US Adults With Atherosclerotic Cardiovascular Disease: Analysis of the Medical Expenditure Panel Survey From 2002 to 2013 (2016) (0)
PRE-MORBID BODY MASS INDEX, HIGH SENSITIVITY TROPONIN-T AND MORTALITY AFTER INCIDENT HEART FAILURE HOSPITALIZATION: THE ATHEROSCLEROSIS RISK IN COMMUNITIES STUDY (ARIC) (2015) (0)
NTPROBNP AND INCIDENT CARDIOVASCULAR EVENTS ACROSS SYSTOLIC BLOOD PRESSURE (SBP) CATEGORIES IN THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY (2018) (0)
Abstract 15427: Sociodemographic Disparities in Influenza Vaccination Among Adults With Atherosclerotic Cardiovascular Disease in the United States (2019) (0)
Abbreviated Title ( Length 26 characters ) : Heart-Carotid Pulse Wave Velocity 2 . Writing Group : Ozlem Bilen (2015) (0)
HYPERTENSION GUIDELINES AND CORONARY ARTERY CALCIFICATION AMONG SOUTH ASIANS: MEDIATORS OF ATHEROSCLEROSIS IN SOUTH ASIANS LIVING IN AMERICA (MASALA) AND MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA) (2020) (0)
UNDERUTILIZATION OF MEDICAL AND LIFE-STYLE INTERVENTIONS IN PATIENTS WITH CANCER AND CARDIOVASCULAR DISEASE. AN ANALYSIS OF THE BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM, 2011-2019 (2023) (0)
Association of Internet Use With the Use of Addictive Substances in The United States. (2020) (0)
Abstract 17986: Multiple Single Day Blood Pressure Measurements and Their Impact on Coronary Heart Disease, Stroke, and Heart Failure Risk Prediction: The Atherosclerosis Risk In Communities (ARIC) Study (2013) (0)
Abstract 14591: Cost-Effectiveness of the American College of Cardiology/American Heart Association and US Preventative Services Task Force Cholesterol Management Guidelines: The Multi-Ethnic Study of Atherosclerosis (2018) (0)
incident CVD : the ARIC study b . Abbreviated Title ( Length 26 characters ) : Lp ( a ) and sdLDL and incident CVD in ARIC 2 (2011) (0)
Hearing Aid Use Status and All-Cause and Cause-Specific Dementia and the Roles of Mediators and Moderators: A Prospective Analysis of UK Biobank Data (2022) (0)
Characteristics and outcomes in acute myocardial infarction hospitalizations among the older population (age ≥80 years) in the United States, 2004-2018. (2023) (0)
TEMPORAL CHANGES IN LIPOPROTEIN(A) LEVELS - THE ATHEROSCLEROSIS RISK IN COMMUNITIES STUDY (2022) (0)
FACILITY-LEVEL VARIATION IN CARDIAC STRESS TEST UTILIZATION AMONG PATIENTS WITH DIABETES MELLITUS: FINDINGS FROM THE VETERANS AFFAIRS NATIONAL DATABASE (2020) (0)
Abstract MP074: High-sensitivity C-reactive Protein and Family History in the Prediction of Risk for Coronary Heart Disease: The Atherosclerosis Risk in Communities Study (2012) (0)
Abstract 18914: Comparison of Statin Eligibility Using the Pooled Cohort Equations, ATP-III Framingham and Reynolds Risk Scores Among Adults Who Experienced ASCVD Events: The Atherosclerosis Risk in Communities Study (2015) (0)
Decrease the incentives to order lipid panels--reply. (2014) (0)
Comparative analysis of revascularization with percutaneous coronary intervention versus coronary artery bypass surgery for patients with end-stage renal disease: a nationwide inpatient sample database (2021) (0)
THE ASSOCIATION OF CARDIOVASCULAR RISK FACTORS AND CALCIUM VOLUME, DENSITY, NUMBER, AND TYPE OF CORONARY VESSEL WITH CALCIFIED PLAQUE IN SOUTH ASIANS LIVING IN THE US AND OTHER RACIAL/ETHNIC GROUPS: COMPARING MASALA AND MESA STUDIES (2020) (0)
ASSOCIATION BETWEEN FREQUENCY OF PCP VISITS AND EVIDENCE-BASED STATIN PRESCRIBING AND STATIN ADHERENCE: FINDINGS FROM THE VETERANS AFFAIRS NATIONAL DATABASE (2019) (0)
CHANGES IN THIGH MUSCLE VOLUME OVER A ONE YEAR PERIOD IN PATIENTS WITH PERIPHERAL ARTERIAL DISEASE (PAD): A MAGNETIC RESONANCE IMAGING (MRI) ANALYSIS FROM THE EFFECT OF LIPID MODIFICATION ON PERIPHERAL ARTERIAL DISEASE AFTER ENDOVASCULAR INTERVENTION TRIAL (ELIMIT) (2010) (0)
Comparison of Premature, Extremely Premature, and Older Adults With Coronary Artery Disease in Pakistan (2023) (0)
Abstract 14928: Burden and Consequences of Medical Debt From Healthcare Bills Among Non-Elderly Adults With Atherosclerotic Cardiovascular Disease in the United States (2018) (0)
Lipid management: Considerations in acute coronary syndrome (2009) (0)
Abstract 11918: The Interplay of Ethnicity and Education With the American Heart Association’s Life’s Simple 7 Metrics: The Baptist Health South Florida Employee Study (2015) (0)
Abstract 13919: Comparison of Clinical Outcomes After Trans-catheter Aortic Valve Implantation in Men and Women for Severe Aortic Stenosis (2013) (0)
Abstract 18851: Trends in Statin Utilization and Expenditures Among US Adult Population: Insight From Medical Expenditure Panel Survey (2002-2013) (2016) (0)
Abstract P43: Frequency and Predictors of Low-Density Lipoprotein Cholesterol Control and Appropriate Response to Elevated LDL-C Levels in Patients with Cardiovascular Disease (2011) (0)
CONTEMPORARY PATTERNS OF LIPID TESTING IN PRIMARY AND SECONDARY PREVENTION PATIENTS: INSIGHTS FROM THE PALM REGISTRY (2017) (0)
Abstract MP05: Life’s Simple 7 and Incident Heart Failure: The Multi-Ethnic Study of Atherosclerosis (2016) (0)
VARIATION IN CARE PRACTICES FOR ACUTE MYOCARDIAL INFARCTION WITH MULTIVESSEL CORONARY ARTERY DISEASE PRESENTING WITH CARDIOGENIC SHOCK IN THE UNITED STATES, 2009-2018: A REPORT FROM THE NCDR RESEARCH TO PRACTICE (R2P) INITIATIVE (2020) (0)
Emerging Lipid-Lowering Therapies in Secondary Prevention (2019) (0)
16: INCIDENCE OF CARDIOVASCULAR DISEASE IN VETERANS WITH INFLAMMATORY BOWEL DISEASE: DATA FROM A LARGE COHORT OF UNITED STATES VETERANS FROM 2002 TO 2015. (2022) (0)
Statins and Primary Atherosclerotic Cardiovascular Disease Prevention-What We Know, Where We Need to Go, and Why Are We Not There Already? (2022) (0)
The importance of low-density lipoprotein cholesterol measurement and control as performance measures: A joint clinical perspective from the National Lipid Association and the American Society for Preventive Cardiology (2023) (0)
Abstract 195: Statin Use and Its Facility Level Variation in Patients With Ischemic Cerebrovascular Disease: Insights From the Department of Veterans Affairs (2017) (0)
Abstract 18999: The Evolution of Heart Failure Trials: 1986-Present (2017) (0)
Natriuretic peptides, extracellular volume, and subclinical cardiovascular changes in chronic kidney disease stages 1–3: a pilot study (2022) (0)
A17033 Cardio-metabolic disease risk factors among South Asian labour migrants to Middle East: A call for action (2018) (0)
Trends in pneumococcal vaccination in patients presenting with acute coronary syndrome in the United States. (2021) (0)
Cluster Randomized Trial Of A Personalized Clinical Decision Support Intervention To Improve Statin Prescribing In Patients With Atherosclerotic Cardiovascular Disease (PCDS Statin). (2023) (0)
SAFETY OF ISOLATED VERSUS COMBINED MVR AND CABG PROCEDURES IN PATIENTS WITH CONCOMITANT MITRAL VALVE AND CORONARY ARTERY DISEASE; A NATIONAL INPATIENT SAMPLE DATABASE ANALYSIS (2022) (0)
Abstract 20656: Publication Rates of Abstracts Presented at Major Cardiovascular Subspecialty Conferences (2016) (0)
PO466 A Club-Based Medication Delivery Strategy For Patients With Hypertension In Nigeria (CLUBMEDS): A Feasibility Study (2018) (0)
Abstract 15682: Does Gender Still Influence Mortality Post Percutaneous Coronary Intervention (PCI)? A Meta-Analysis of the Impact of Gender on PCI Outcomes (2014) (0)
PCI OR CORONARY ARTERY BYPASS GRAFT: IMPLICATIONS IN END–STAGE RENAL DISEASE PATIENTS (2013) (0)
Are All Benefits and Harms Equal? (2018) (0)
Abstract 12042: The "Obesity Paradox" in Ambulatory Patients With Heart Failure With Preserved Ejection Fraction (2013) (0)
Persistent Racial/Ethnic Disparities in Cardiology Trainees in the United States. (2022) (0)
IMPACT OF SHORT VERSUS LONG DURATION DUAL ANTIPLATELET THERAPY ON CLINICAL OUTCOMES: A COMPREHENSIVE META-ANALYSIS OF ALL RANDOMIZED CLINICAL TRIALS (2015) (0)
Trends, predictors, and outcomes of transcatheter aortic valve implantation in patients with bicuspid aortic valve related disease: Insights from the Nationwide Inpatient Sample and Nationwide Readmission Database (2022) (0)
Abstract 14054: Soluble ACE2, Cardiac Biomarkers, Structure, Function and Events: The Atherosclerosis Risk in Communities (ARIC) Study (2020) (0)
Revisiting diuretic choice in chronic kidney disease. (2022) (0)
SEGMENTAL ANALYSIS OF CIRCUMFERENTIAL SYSTOLIC CAROTID ARTERIAL STRAIN IN DIABETICS AND HYPERTENSIVES USING 2D SPECKLE TRACKING (2012) (0)
Corrigendum for “Acute Aortic Valve Rupture From Infective Endocarditis” (2013) (0)
Role of Lipid-Lowering Therapy in Peripheral Artery Disease (2022) (0)
South Asian ethnicity: What can we do to make this risk enhancer a risk equivalent? (2022) (0)
Mortality reduction with PCSK9 inhibition: A case of cautious optimism. (2019) (0)
Abstract 17888: Catastrophic Health Expenditures: A Financial Adverse Effect of Coronary Artery Bypass Grafting in the Uninsured (2017) (0)
The Reply. (2020) (0)
From the EAS:* frequent questions and responses on the 2022 lipoprotein(a) consensus statement of the European Atherosclerosis Society (2023) (0)
Abstract 17117: Burden of Catastrophic Health Expenditures for Acute Myocardial Infarction and Stroke Hospitalizations Among Uninsured in the United States (2017) (0)
Abstract 15958: Burden and Consequences of Financial Hardship From Medical Bills Among Non-Elderly Adults With Diabetes Mellitus in The United States (2019) (0)
The Impact of the Affordable Care Act on Disparities in Utilization of Cardiovascular Preventive Services by Socioeconomic Status. (2020) (0)
Images in Echocardiography: A Freely Floating Saphenous Vein Graft (2009) (0)
A stepwise approach to prescribing novel lipid-lowering medications. (2022) (0)
VHRM_A_210149 1..10 (2020) (0)
Abstract 118: Are Patients with Atherosclerotic Cardiovascular Disease Receiving Appropriate Lipid Management? Insights from the PALM Registry (2016) (0)
Chapter 42 – Hyperlipidemia (2018) (0)
Does Coronary Plaque Morphology Matter Beyond Plaque Burden? (2023) (0)
TREND AND PREDICTORS OF TAVI RELATED IN-HOSPITAL MORTALITY - A NATIONAL INPATIENT SAMPLE DATABASE (2021) (0)
Association between circulating Galectin-3 and arterial stiffness in older adults. (2021) (0)
IMPACT OF FEMALE GENDER ON MORTALITY AFTER ISOLATED CORONARY ARTERY BYPASS GRAFTING (2013) (0)
PATIENT PERCEPTIONS AND MANAGEMENT OF CHOLESTEROL AMONG INDIVIDUALS WITH OR WITHOUT DIABETES IN COMMUNITY PRACTICE: RESULTS FROM THE PALM REGISTRY (2019) (0)
Abstract 14212: Sex Differences in the Age of Diagnosis for Cardiovascular Disease and Its Risk Factors Among Us Adults; Trends From 2008-2017, the Medical Expenditure Panel Survey (2020) (0)
Trends in Undiagnosed Diabetes Mellitus Among United States Adults: Cross-Sectional Analyses from NHANES 2011-2020. (2022) (0)
Abstract 15779: Unfavorable Social Determinants of Health Profile and Financial Toxicity From Healthcare in Atherosclerotic Cardiovascular Disease (2020) (0)
TRENDS OF TRANSCATHETER AORTIC VALVE IMPLANTATION IN PATIENTS WITH AORTIC INSUFFICIENCY (2022) (0)
1 Subsequent Event Risk in Individuals with Established Coronary Heart Disease : Design and Rationale of the GENIUS-CHD Consortium Running title : (2019) (0)
SHARED DECISION MAKING AND PATIENT REPORTED OUTCOMES AMONG ADULTS WITH ATHEROSCLEROTIC CARDIOVASCULAR DISEASE, MEDICAL EXPENDITURE PANEL SURVEY 2006-2015 (2020) (0)
Abbreviated Title ( Length 26 characters ) : BNP in obesity and HFpEF 2 (2013) (0)
Abstract MP27: Cardiovascular Biomarkers and MRI-defined Small Vessel Disease of the Brain in the Atherosclerosis Risk in Communities (ARIC) Study (2013) (0)
Adherence Clubs to Improve Hypertension Management in Nigeria: Clubmeds, a Feasibility Study (2022) (0)
Childhood Oral Infections and Subclinical Atherosclerosis in Adulthood: Should We Wait for Causality or Just Treat? (2019) (0)
VARIATION IN THE USE OF DIRECT ORAL ANTICOAGULANTS AND ASSOCIATED COST IMPLICATIONS: FINDINGS FROM THE MEDICAL EXPENDITURE PANEL SURVEY 2010 TO 2013 (2017) (0)
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2023 American College of Cardiology Conference. (2023) (0)
THE IMPACT OF COLCHICINE ON THE INCIDENCE AND RECURRENCE OF PERICARDIAL INFLAMMATION: A COMPREHENSIVE META-ANALYSIS OF ALL RANDOMIZED CLINICAL TRIALS (2012) (0)
Abstract 244: Sex-based Differences in Economic and Health-related Burden of Depression on Adults With Cardiovascular Disease (2016) (0)
Association of Small Dense Low-Density Lipoprotein Cholesterol and Lipoprotein-Associated Phospholipase A2 with Carotid Plaque Characteristics in the Atherosclerosis Risk in Communities Study* (2014) (0)
OUTCOMES OF TRANSCATHETER AORTIC VALVE IMPLANTATION IN FEMALES VS. MALES WITH SEVERE AORTIC STENOSIS (2022) (0)
Abstract 16254: Heart Rate as a Prognostic Marker in Patients With Heart Failure With Preserved Ejection Fraction (2015) (0)
THE PROGNOSTIC ROLE OF SOLUBLE SUPPRESSION OF TUMORIGENICITY 2 (SST2) AMONG OLDER ADULTS: ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY (2021) (0)
Healthcare Access Among Individuals of Asian Descent in the U.S (2022) (0)
Imaging subclinical coronary atherosclerosis to guide lipid management, are we there yet? (2022) (0)
DIABETIC STATUS DOES NOT AFFECT PLATELET FUNCTION ASSAYS IN PERIPHERAL ARTERIAL DISEASE PATIENTS ON HIGH DOSE ASPIRIN: AN ANALYSIS FROM THE EFFECT OF LIPID MODIFICATION ON PERIPHERAL ARTERIAL DISEASE AFTER ENDOVASCULAR INTERVENTION (ELIMIT) TRIAL (2011) (0)
Trends in Patient-Recalled Targets for Cardiovascular Risk Factors in Ambulatory US Adults With Diabetes Mellitus (from National Health and Nutrition Examination Survey). (2021) (0)
Variability and Persistence of Poor Response to Aspirin by Aggregometry and PFA-100 over Twelve-Months in Peripheral Arterial Disease from the Effect of Lipid Modification on Peripheral Arterial Disease after Endovascular Intervention Trial (ELIMIT) (2011) (0)
Abstract 14992: Outcomes of Off-Label Use of Transcatheter Aortic Valve Replacement (TAVR) in the U.S.: Insights From the STS/ACC TVT Registry (2015) (0)
IMPACT OF COMORBIDITIES ON HEART FAILURE HOSPITALIZATIONS AND ALL CAUSE HOSPITALIZATIONS IN AMBULATORY PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION (2013) (0)
State-Level Temporal Trends in Smokeless Tobacco and Cigarette Use Among U.S. Adults. (2020) (0)
Reply: Frequency of inappropriate and nonrecommended prasugrel prescription: great variations. (2014) (0)
CHRONIC TOTAL OCCLUSIONS: IMPACT OF SUCCESSFUL AND FAILED RECANALIZATION ON SHORT AND LONG–TERM SURVIVAL (2013) (0)
Abstract 19534: Hemodynamic Effects of Ultrasound-Guided Catheter Directed Thrombolysis (UCDT) in Patients With Massive or Sub-Massive Pulmonary Embolism (2014) (0)
COST, RESOURCE UTILIZATION, QUALITY OF LIFE, MENTAL HEALTH, AND FINANCIAL TOXICITY AMONG YOUNG ADULTS WITH STROKE IN THE UNITED STATES (2020) (0)
FACILITY LEVEL VARIATION IN THE REPORTING OF STATIN-ASSOCIATED SIDE EFFECTS AMONG PATIENTS WITH ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (2021) (0)
Abstract 12916: Cost-Related Medication Non-Adherence in Nonelderly With Atherosclerotic Cardiovascular Disease in the United States, 2013-2016 (2018) (0)
Abstract 328: Coronary Artery Disease Performance Measures And Statin Use Between Patients With Recent Percutaneous Coronary Intervention (PCI)and Patients With Recent Coronary Artery Bypass Grafting (CABG): An Analysis From The NCDR®. (2013) (0)
Abstract 15982: Association of Electrocardiographic Parameters With Cardiac Troponin-T Measured With a High Sensitivity Assay in the Atherosclerosis Risk in Communities Study (2013) (0)
TCT-760 All-Cause Mortality after Surgical or Trans-Catheter Aortic Valve Replacement in Patients with Low-Flow Low-Gradient Aortic Stenosis (2013) (0)
Commentaries on health services research (2018) (0)
Readmission in Patients With ST-Elevation Myocardial Infarction in 4 Age Groups (<45, >45 to <60, 60 to <75, and >75). (2022) (0)
Abstract 88: The effect of statins on incidence of infections after Coronary Artery Bypass Grafting (2012) (0)
Abstract 17106: Impact of Communication Format and Risk Horizon on Patient Perceptions of CVD Risk: Findings From the PALM Registry (2016) (0)
Abstract 15540: Prevalence and Sociodemographic Determinants of Food Insecurity Among Adults With Atherosclerotic Cardiovascular Disease in the United States (2020) (0)
1159-191 Effect of a single high-fat meal on endothelial microparticles as a marker of endothelial injury (2004) (0)
Lipid-Lowering Therapy Use and Intensification Among United States Veterans Following Myocardial Infarction or Coronary Revascularization Between 2015 and 2019 (2022) (0)
ASSOCIATION OF CARDIOVASCULAR RISK PROFILE WITH ALL-CAUSE AND CARDIOVASCULAR MORTALITY IN NON-ELDERLY US ADULTS, 2006-2014 (2022) (0)
Abstract 13068: Measures of Adiposity and Presence of Subclinical Atherosclerosis in Retired National Football League Players (2011) (0)
Comparison of Longitudinal Skeletal Thigh Muscle Findings With Magnetic Resonance Imaging in Patients With Peripheral Artery Disease With-Versus-Without Diabetes Mellitus. (2022) (0)
Cardiac Troponin T Measured by a Highly Sensitive Assay Predicts Coronary Heart Disease, Heart Failure, and Mortality in the ARIC Study (2011) (0)
Abstract 11202: Life’s Simple 7 and Incident Atrial Fibrillation: The Multi-Ethnic Study of Atherosclerosis (2016) (0)
Factors Associated With Sex Disparities in Leisure-Time Physical Activity: An Analysis of the Behavioral Risk Factor Surveillance System, 2011 to 2021. (2023) (0)
HIGH SENSITIVITY TROPONIN IS ASSOCIATED WITH MORTALITY, CORONARY HEART DISEASE AND HEART FAILURE IN INDIVIDUALS WITH PREVALENT CARDIOVASCULAR DISEASE IN THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY (2011) (0)
Clinical and Economic Profile of Homeless Young Adults with Stroke in the United States, 2002 - 2017. (2022) (0)
1.a. Full Title: Troponin T and N-terminal pro-B-type Natriuretic Peptide and Cognitive Decline and Dementia in the ARIC study (2014) (0)
DISCORDANCE BETWEEN TRADITIONAL LIPID PARAMETERS, APOLIPOPROTEINS AND LIPOPROTEIN PARTICLE NUMBER: INSIGHTS FROM THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) CAROTID MRI STUDY (2010) (0)
COST-EFFECTIVENESS OF CORONARY ARTERY CALCIUM TO GUIDE PCSK9 INHIBITOR THERAPY AMONG PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA (2020) (0)
Abstract 9844: Clinical Outcomes of Saphenous Vein Graft Interventions Using Drug Eluting Stents Compared with Bare Metal Stents: A Comprehensive Meta-Analysis of All Randomized Clinical Trials (2011) (0)
Social media and predictive analysis regarding dietary approaches to stop hypertension. (2021) (0)
Abstract 19554: Is Coronary Artery Bypass Grafting (CABG) with Cardiopulmonary Bypass Support (On-pump) Superior to CABG Without Bypass Support (Off-pump) in the High-Risk?: A Meta-Analysis of Randomized Controlled Trials (RCTs) (2014) (0)
Eligibility for Low-Dose Rivaroxaban Based on the COMPASS Trial: Insights from the Veterans Affairs Healthcare System (2020) (0)
RADIAL VERSUS FEMORAL ACCESS FOR PERCUTANEOUS CORONARY INTERVENTION IN NON-ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: A META-ANALYSIS OF 38,587 PATIENTS (2015) (0)
Abstract 17321: Guideline Recommended Statin Therapy Implementation and Cardiovascular Outcomes: Insights From a Multi-Site Healthcare Primary Prevention Cohort (2020) (0)
OUTCOMES AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT IN CANCER SURVIVORS WITH PRIOR CHEST RADIATION THERAPY: AN UPDATED SYSTEMATIC REVIEW AND META-ANALYSIS (2023) (0)
LIPOPROTEIN(A) IS ASSOCIATED WITH INCIDENT HEART FAILURE HOSPITALIZATION: ARIC STUDY (2016) (0)
Abstract 157: Assessment of Financial Hardship From Medical Bills Across the Spectrum of Diabetes Mellitus and Atherosclerotic Cardiovascular Disease Among Non-Elderly Adults in the United States (2019) (0)
Gender Differences in Premature Coronary Artery Disease (from the National Data from the NHANES Database). (2021) (0)
Correction to: Cardiovascular Disease Prevention: Training Opportunities, the Challenges, and Future Directions (2018) (0)
Abstract P241: 2013 AHA/ACC/TOS and 1998 NHLBI Clinical Guidelines for the Management of Overweight and Obesity Predict Higher Cardiovascular Disease Risk in Adults Recommended versus Not Recommended for Weight Loss Treatment: the Atherosclerosis Risk in Communities Study (2015) (0)
Coronary Artery Plaque Assessment by CT Angiogram in Inflammatory Bowel Disease. (2023) (0)
PROGNOSTIC IMPLICATIONS OF ABSENCE OF CORONARY ARTERY CALCIUM IN ASYMPTOMATIC INDIVIDUALS WITH TYPE 2 DIABETES MELLITUS: A SYSTEMATIC REVIEW AND META-ANALYSIS (2020) (0)
Abstract 16634: Treatment Patterns & Clinical Outcomes Among Asian Americans With Atrial Fibrillation: An Analysis From the NCRD® PINNACLE Registry (2020) (0)
CLINICIANS’ SELF-REPORTED EFFICACY IN CARDIOVASCULAR PREVENTION PRACTICE IN THE SOUTHEASTERN UNITED STATES (2023) (0)
A comparison of cardiovascular risk factors between Asian-Americans and non-Asian Americans: An analysis from the NHANES database. (2021) (0)
Abstract 16990: Impact of 2013 ACC/AHA Cholesterol Management Guidelines on Statins Use Among Nationally Representative Adult Populations in United States: Medical Expenditure Panel Survey (2010-2015) (2018) (0)
Identifying Differences: A Key Step in Precision Cardiovascular Disease Prevention (2022) (0)
Erratum to: Efficacy of Angiotensin-Converting Enzyme Inhibitors and Angiotensin-Receptor Blockers in Coronary Artery Disease without Heart Failure in the Modern Statin Era: a Meta-Analysis of Randomized-Controlled Trials (2016) (0)
“All hands on deck”: An imperative for tackling hypertension in South Asia (2017) (0)
Leveraging Clinical Digitized Data to Understand Temporal Characteristics and Outcomes of Acute Myocardial Infarctions at a Tertiary Care Medical Centre in Pakistan from 1988–2018 – Methods and Results (2022) (0)
TWELVE MONTH PERSISTENCE OF POOR RESPONSE TO ASPIRIN IN PATIENTS WITH PERIPHERAL ARTERIAL DISEASE ENROLLED IN THE EFFECT OF LIPID MODIFICATION ON PERIPHERAL ARTERIAL DISEASE AFTER ENDOVASCULAR INTERVENTION TRIAL (ELIMIT) (2010) (0)
CLINICAL OUTCOMES OF PATIENTS WITH HUMAN IMMUNE DEFICIENCY VIRUS AFTER CORONARY REVASCULARIZATION: A SYSTEMATIC REVIEW AND META-ANALYSIS (2017) (0)
Racial/Ethnic Disparities and Determinants of Sufficient Physical Activity Levels (2022) (0)
Abstract 16424: Cardiovascular Risk Factors Among a Nationally Representative Adult Population With Inflammatory Bowel Disease and Without Clinical Atherosclerotic Cardiovascular Disease (2020) (0)
Abstract 13: Economic Impact of Moderate-vigorous Physical Activity Among Those with and without Established Cardiovascular Disease: 2012 Medical Expenditure Panel Survey (2016) (0)
Abstract 11163: Lipid Monitoring and Treatment Intensification of Cholesterol Lowering Therapies - Insight From the Veterans Affairs Healthcare System (2019) (0)
Abstract 27: Mining Big Data to Estimate the Frailty Index in Patients with Congestive Heart Failure: Clinical Expert vs Machine Learning (2019) (0)
STATIN PRESCRIPTION RATES, ADHERENCE, AND ASSOCIATED CLINICAL OUTCOMES AMONG WOMEN WITH PERIPHERAL ARTERIAL DISEASE AND ISCHEMIC CEREBROVASCULAR DISEASE (2020) (0)
Have practice guidelines led to optimal management of non-HDL cholesterol? (2011) (0)
PREDICTORS OF STATIN USE FOR PATIENTS WITH LDL CHOLESTEROL ABOVE 190MG/DL: INSIGHTS FROM THE VETERANS AFFAIRS HEALTH CARE SYSTEM (2017) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Salim S. Virani?

Salim S. Virani is affiliated with the following schools:

Salim S. Virani's Academic­Influence.com Rankings

Salim S. Virani's Degrees

Similar Degrees You Can Earn

Why Is Salim S. Virani Influential?

Salim S. Virani's Published Works

Published Works

What Schools Are Affiliated With Salim S. Virani?

Salim S. Virani's AcademicInfluence.com Rankings